An acute infectious disease primarily of the tropics, caused by a virus and transmitted to man by mosquitoes of the genera Aedes and Haemagogus. The severe form is characterized by fever, HEMOLYTIC JAUNDICE, and renal damage.
The type species of the FLAVIVIRUS genus. Principal vector transmission to humans is by AEDES spp. mosquitoes.
Vaccine used to prevent YELLOW FEVER. It consists of a live attenuated 17D strain of the YELLOW FEVER VIRUS.
An abnormal elevation of body temperature, usually as a result of a pathologic process.
A genus of mosquitoes (CULICIDAE) frequently found in tropical and subtropical regions. YELLOW FEVER and DENGUE are two of the diseases that can be transmitted by species of this genus.
A genus of FLAVIVIRIDAE containing several subgroups and many species. Most are arboviruses transmitted by mosquitoes or ticks. The type species is YELLOW FEVER VIRUS.
A genus of the subfamily ALOUATTINAE, family ATELIDAE, inhabiting the forests of Central and South America. Howlers travel in groups and define their territories by howling accompanied by vigorously shaking and breaking branches.
An acute infectious disease caused by COXIELLA BURNETII. It is characterized by a sudden onset of FEVER; HEADACHE; malaise; and weakness. In humans, it is commonly contracted by inhalation of infected dusts derived from infected domestic animals (ANIMALS, DOMESTIC).
Infections with viruses of the genus FLAVIVIRUS, family FLAVIVIRIDAE.
Insects that transmit infective organisms from one host to another or from an inanimate reservoir to an animate host.
An acute systemic febrile infection caused by SALMONELLA TYPHI, a serotype of SALMONELLA ENTERICA.
A family of the order DIPTERA that comprises the mosquitoes. The larval stages are aquatic, and the adults can be recognized by the characteristic WINGS, ANIMAL venation, the scales along the wing veins, and the long proboscis. Many species are of particular medical importance.
A species of the genus FLAVIVIRUS which causes an acute febrile and sometimes hemorrhagic disease in man. Dengue is mosquito-borne and four serotypes are known.
Infections caused by arthropod-borne viruses, general or unspecified.
Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease.
I'm sorry for any confusion, but there seems to be a misunderstanding as "South America" is not a medical term and cannot have a medical definition. It is a geographical term referring to the southern portion of the American continent, consisting of twelve independent countries and three territories of other nations.
Fever in which the etiology cannot be ascertained.
A group of viral diseases of diverse etiology but having many similar clinical characteristics; increased capillary permeability, leukopenia, and thrombocytopenia are common to all. Hemorrhagic fevers are characterized by sudden onset, fever, headache, generalized myalgia, backache, conjunctivitis, and severe prostration, followed by various hemorrhagic symptoms. Hemorrhagic fever with kidney involvement is HEMORRHAGIC FEVER WITH RENAL SYNDROME.
Arthropod-borne viruses. A non-taxonomic designation for viruses that can replicate in both vertebrate hosts and arthropod vectors. Included are some members of the following families: ARENAVIRIDAE; BUNYAVIRIDAE; REOVIRIDAE; TOGAVIRIDAE; and FLAVIVIRIDAE. (From Dictionary of Microbiology and Molecular Biology, 2nd ed)
Multidisciplinary field focusing on prevention of infectious diseases and patient safety during international TRAVEL. Key element of patient's pre-travel visit to the physician is a health risk assessment.
Immunoglobulins produced in response to VIRAL ANTIGENS.
An acute febrile disease transmitted by the bite of AEDES mosquitoes infected with DENGUE VIRUS. It is self-limiting and characterized by fever, myalgia, headache, and rash. SEVERE DENGUE is a more virulent form of dengue.
A CELL LINE derived from the kidney of the African green (vervet) monkey, (CERCOPITHECUS AETHIOPS) used primarily in virus replication studies and plaque assays.
Vaccines or candidate vaccines used to prevent infection with WEST NILE VIRUS.
A febrile disease occurring as a delayed sequela of infections with STREPTOCOCCUS PYOGENES. It is characterized by multiple focal inflammatory lesions of the connective tissue structures, such as the heart, blood vessels, and joints (POLYARTHRITIS) and brain, and by the presence of ASCHOFF BODIES in the myocardium and skin.
Slender tubular or hairlike excretory structures found in insects. They emerge from the alimentary canal between the mesenteron (midgut) and the proctodeum (hindgut).
Aspects of health and disease related to travel.
Proteins encoded by a VIRAL GENOME that are produced in the organisms they infect, but not packaged into the VIRUS PARTICLES. Some of these proteins may play roles within the infected cell during VIRUS REPLICATION or act in regulation of virus replication or VIRUS ASSEMBLY.
Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity.
A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey (C. pygerythrus) is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research.
An acute infection caused by the RIFT VALLEY FEVER VIRUS, an RNA arthropod-borne virus, affecting domestic animals and humans. In animals, symptoms include HEPATITIS; abortion (ABORTION, VETERINARY); and DEATH. In humans, symptoms range from those of a flu-like disease to hemorrhagic fever, ENCEPHALITIS, or BLINDNESS.
Sudden increase in the incidence of a disease. The concept includes EPIDEMICS and PANDEMICS.
An acute febrile human disease caused by the LASSA VIRUS.
The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50).
Layers of protein which surround the capsid in animal viruses with tubular nucleocapsids. The envelope consists of an inner layer of lipids and virus specified proteins also called membrane or matrix proteins. The outer layer consists of one or more types of morphological subunits called peplomers which project from the viral envelope; this layer always consists of glycoproteins.
Proteins found in any species of insect.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis.
I'm sorry for any confusion, but "Brazil" is not a medical term or concept, it is a country located in South America, known officially as the Federative Republic of Brazil. If you have any questions related to health, medicine, or science, I'd be happy to help answer those!
Central America is not a medical term, but a geographical region consisting of seven countries (Belize, Guatemala, Honduras, El Salvador, Nicaragua, Costa Rica, and Panama) that connect North America to South America, which may be relevant in medical contexts such as discussions of regional disease patterns, public health initiatives, or tropical medicine.
Time period from 1801 through 1900 of the common era.
Method for measuring viral infectivity and multiplication in CULTURED CELLS. Clear lysed areas or plaques develop as the VIRAL PARTICLES are released from the infected cells during incubation. With some VIRUSES, the cells are killed by a cytopathic effect; with others, the infected cells are not killed but can be detected by their hemadsorptive ability. Sometimes the plaque cells contain VIRAL ANTIGENS which can be measured by IMMUNOFLUORESCENCE.
A severe, often fatal disease in humans caused by the Crimean-Congo hemorrhagic fever virus (HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO).
Invertebrates or non-human vertebrates which transmit infective organisms from one host to another.
Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination.
Ribonucleic acid that makes up the genetic material of viruses.
I'm afraid there seems to be a misunderstanding - "Africa" is not a medical term and does not have a medical definition. Africa is the world's second-largest and second-most populous continent, consisting of 54 countries with diverse cultures, peoples, languages, and landscapes. If you have any questions related to medical topics or definitions, I would be happy to help answer those for you!
A febrile disease of the Mediterranean area, the Crimea, Africa, and India, caused by infection with RICKETTSIA CONORII.
The relationships of groups of organisms as reflected by their genetic makeup.
Infectious diseases that are novel in their outbreak ranges (geographic and host) or transmission mode.
An acute febrile disease occurring predominately in Asia. It is characterized by fever, prostration, vomiting, hemorrhagic phenonema, shock, and renal failure. It is caused by any one of several closely related species of the genus Hantavirus. The most severe form is caused by HANTAAN VIRUS whose natural host is the rodent Apodemus agrarius. Milder forms are caused by SEOUL VIRUS and transmitted by the rodents Rattus rattus and R. norvegicus, and the PUUMALA VIRUS with transmission by Clethrionomys galreolus.
Light absorbing proteins and protein prosthetic groups found in certain microorganisms. Some microbial photoreceptors initiate specific chemical reactions which signal a change in the environment, while others generate energy by pumping specific ions across a cellular membrane.

Candidate viral diseases for elimination or eradication. (1/292)

This article discusses the possibilities for elimination or eradication of four viral diseases--measles, hepatitis B, rubella and yellow fever.  (+info)

Vectors of Chikungunya virus in Senegal: current data and transmission cycles. (2/292)

Chikungunya fever is a viral disease transmitted to human beings by Aedes genus mosquitoes. From 1972 to 1986 in Kedougou, Senegal, 178 Chikungunya virus strains were isolated from gallery forest mosquitoes, with most of them isolated from Ae. furcifer-taylori (129 strains), Ae. luteocephalus (27 strains), and Ae. dalzieli (12 strains). The characteristics of the sylvatic transmission cycle are a circulation periodicity with silent intervals that last approximately three years. Few epidemics of this disease have been reported in Senegal. The most recent one occurred in 1996 in Kaffrine where two Chikungunya virus strains were isolated from Ae. aegypti. The retrospective analysis of viral isolates from mosquitoes, wild vertebrates, and humans allowed to us to characterize Chikungunya virus transmission cycles in Senegal and to compare them with those of yellow fever virus.  (+info)

First case of yellow fever in French Guiana since 1902. (3/292)

The first case of yellow fever in French Guiana since 1902 was reported in March 1998. The yellow fever virus genome was detected in postmortem liver biopsies by seminested polymerase chain reaction. Sequence analysis showed that this strain was most closely related to strains from Brazil and Ecuador.  (+info)

Automated measurement of oxygen consumption by the yellow fever mosquito, Aedes aegypti. (4/292)

Oxygen consumption of single mosquitoes was measured using a differential pressure transducer (DPT) connected to two small chambers. A mosquito was placed in the experimental chamber (P1) and was separated from NaOH by 4 cm2 of marquisette mesh. The reference chamber (P2) contained the same amount of NaOH and the marquisette mesh but without a mosquito. When these two chambers were sealed, removed O2 from P1 resulted in a pressure decrease with respect to P2. This pressure differential was transduced into an output voltage that was directly proportional to the amount of O2 consumed by the mosquito. An array of eight DPTs was interfaced with an IBM 486 PC using an ADAC 5500MF analog to digital converter and software from ADAC (Direct View) to automate the recording procedure. We determined that our apparatus was sensitive enough to detect subtle differences in O2 consumption in mosquitoes subjected to different physiologic conditions.  (+info)

Comparison of the immunogenicity and safety of two 17D yellow fever vaccines. (5/292)

As part of the clinical validation process of a new working seed of a licensed yellow fever vaccine (new working seed PV26, Stamaril; Pasteur Merieux Connaught, Lyon, France), the immunogenicity and safety of two batches of this vaccine (PM-YF) were compared with those of another commercially available vaccine (Arilvax; Evans Medical-Wellcome, Liverpool, United Kingdom) in 211 healthy adults. While the geometric mean titer values at days 10-14 and day 28 after vaccination were higher in the PM-YF group, the vaccines provided equivalent seroprotection (titers > or = 1/10) one month after a single vaccine dose (100% PM-YF versus 99% W-YF; P = 0.001, by one-sided equivalence test). Both vaccines were safe. There were no serious local or systemic reactions reported, nor any clinically significant hepatic function abnormalities associated with the use of either vaccine. These two 17D yellow fever vaccines from different European vaccine manufacturers were highly immunogenic and safe, and provided equivalent seroprotection.  (+info)

Japanese encephalitis vaccine (inactivated, BIKEN) in U.S. soldiers: immunogenicity and safety of vaccine administered in two dosing regimens. (6/292)

The safety and immunogenicity of Japanese encephalitis (JE) vaccine (Nakayama strain, monovalent / BIKEN) was studied in 538 U.S. soldiers in 1990. Three doses of vaccine from three consecutively manufactured lots were given on days 0, 7, and either 14 or 30. Serum for antibody determination was drawn at months 0, 2, and 6. Japanese encephalitis plaque reduction neutralization tests were performed by three laboratories on each specimen. Five hundred twenty-eight (98%) participants completed the immunization series. All recipients without antibody before immunization developed neutralizing antibody against JE virus. There were no differences in geometric mean titer among the three test lots at months 2 and 6. Soldiers who received the third dose on day 30 had higher titers at both time points. Antibody to yellow fever had no significant effect on immune response to vaccine. Conclusions drawn from analysis of serologic data from the three labs were nearly identical. Symptoms were generally limited to mild local effects and were reduced in frequency with each subsequent does in the series (21% to 11%; P < 0.0001). Generalized symptoms were rare (e.g., fever = 5%) with no reported cases of anaphylaxis.  (+info)

Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus. (7/292)

Six passages of the mosquito-borne flavivirus yellow fever (YF) wild-type strain Asibi in HeLa cells attenuated the virus for monkeys and newborn mice and resulted in loss of mosquito competence. Attenuation after the passage in HeLa cells was not unique to YF virus strain Asibi as demonstrated by the HeLa passage attenuation of wild-type YF virus strain French viscerotropic virus and YF vaccine virus 17D-204 for newborn mice. In contrast, wild-type strain Dakar 1279 and the French neurotropic vaccine virus remained virulent for newborn mice after six passages in HeLa cells. Thus not all strains of YF virus can be attenuated by passage in HeLa cells. Attenuation of YF virus strains Asibi and French viscerotropic virus was accompanied by alterations in the antigenic and biological properties of the viruses, including changes to envelope protein epitopes. Attenuation for newborn mice was coincidental with the acquisition by the HeLa-passaged viruses of the vaccine-specific envelope protein epitope recognized by monoclonal antibody H5. This suggests that this conformational change may play a role in the attenuation process. Wild-type Dakar 1279, which remained virulent for newborn mice after passage in HeLa cells, retained its wild-type antigenic character. The genome of Asibi HeLa p6 virus differed from wild-type Asibi virus by 29 nucleotides that encoded 10 amino acid substitutions: 5 in the envelope protein, 1 in NS2A, 3 in NS4B, and 1 in NS5. The substitution at NS4B-95 is seen in three different attenuation processes of wild-type YF virus, leading us to speculate that it is involved in the attenuation of virulence of wild-type strain Asibi.  (+info)

Ammonia as an attractive component of host odour for the yellow fever mosquito, Aedes aegypti. (8/292)

Behavioural responses of Aedes aegypti mosquitoes to ammonia were investigated in a modified Y-tube olfactometer. Ammonia was attractive in concentrations from 17 ppb to 17 ppm in air when presented together with lactic acid. Aqueous solutions of ammonia salts in concentrations comparable to those found in human sweat also increased the attractiveness of lactic acid. The role of lactic acid as an essential synergist for ammonia became further apparent by the fact that ammonia alone or in combination with carbon dioxide was not effective, even though the synergistic effect of carbon dioxide and lactic acid was corroborated. An extract from human skin residues, which attracts approximately 80% of the tested mosquitoes, contains both lactic acid and ammonia. The combination of these compounds, however, attracts no more than 45%, indicating that other components on human skin also play a role in host finding. Preparative liquid chromatography of the skin extract yielded three behaviourally active fractions which work together synergistically. Fraction III contains lactic acid as the effective principle; the compositions of the other two have not been clarified yet. The attractiveness of fraction I was augmented considerably when ammonia was added, whereas the effect of fraction II was not influenced by ammonia. These results suggests that ammonia is part of the effective principle of fraction II and contributes to the attractive effect of host odours.  (+info)

Yellow fever is an acute viral hemorrhagic disease that's transmitted to humans through the bite of infected mosquitoes. The "yellow" in the name refers to the jaundice that can occur in some patients, resulting from liver damage caused by the virus. The disease is endemic in tropical regions of Africa and Central and South America.

The yellow fever virus is a single-stranded RNA virus that belongs to the Flaviviridae family, genus Flavivirus. It's closely related to other mosquito-borne viruses like dengue and Zika. The virus has three distinct geographical variants (West African, East African, and South American), each with different epidemiological patterns and clinical features.

The incubation period for yellow fever is typically 3 to 6 days after infection. The initial symptoms include fever, chills, headache, back pain, myalgia, and fatigue. Most patients recover after this initial phase, but around 15% of those infected enter a more severe phase characterized by high fever, jaundice, abdominal pain, vomiting, bleeding, and often rapid death within 7 to 10 days.

There is no specific treatment for yellow fever, and management is focused on supportive care, including fluid replacement, blood transfusions, and addressing any complications that arise. Prevention relies on vaccination and mosquito control measures. The yellow fever vaccine is safe and highly effective, providing immunity in 95% of those who receive it. A single dose offers lifelong protection in most individuals. Mosquito control efforts, such as reducing breeding sites and using insecticide-treated materials, can help prevent the spread of the virus in affected areas.

Yellow fever virus (YFV) is an single-stranded RNA virus belonging to the Flaviviridae family, genus Flavivirus. It is primarily transmitted to humans through the bite of infected mosquitoes, most commonly Aedes and Haemagogus species. The virus is named for the jaundice that can occur in some patients, giving their skin and eyes a yellowish color.

Yellow fever is endemic in tropical regions of Africa and South America, with outbreaks occurring when large numbers of people are infected. After an incubation period of 3 to 6 days, symptoms typically begin with fever, chills, headache, back pain, and muscle aches. In more severe cases, the infection can progress to cause bleeding, organ failure, and death.

Prevention measures include vaccination, mosquito control, and personal protective measures such as wearing long sleeves and using insect repellent in areas where yellow fever is endemic or outbreaks are occurring.

The Yellow Fever Vaccine is a vaccine that protects against the yellow fever virus, which is transmitted to humans through the bites of infected mosquitoes. The vaccine contains live, weakened yellow fever virus, and it works by stimulating the immune system to produce an immune response that provides protection against the disease.

The yellow fever vaccine is recommended for people who are traveling to areas where yellow fever is common, including parts of Africa and South America. It is also required for entry into some countries in these regions. The vaccine is generally safe and effective, but it can cause mild side effects such as headache, muscle pain, and fever in some people. Serious side effects are rare, but may include allergic reactions or infection with the weakened virus used in the vaccine.

It's important to note that yellow fever vaccine may not be recommended for certain individuals, including infants younger than 6 months, pregnant women, people with weakened immune systems, and those with a history of severe allergic reaction to a previous dose of the vaccine or any component of the vaccine. It is always best to consult with a healthcare provider before receiving any vaccination.

Fever, also known as pyrexia or febrile response, is a common medical sign characterized by an elevation in core body temperature above the normal range of 36.5-37.5°C (97.7-99.5°F) due to a dysregulation of the body's thermoregulatory system. It is often a response to an infection, inflammation, or other underlying medical conditions, and it serves as a part of the immune system's effort to combat the invading pathogens or to repair damaged tissues.

Fevers can be classified based on their magnitude:

* Low-grade fever: 37.5-38°C (99.5-100.4°F)
* Moderate fever: 38-39°C (100.4-102.2°F)
* High-grade or severe fever: above 39°C (102.2°F)

It is important to note that a single elevated temperature reading does not necessarily indicate the presence of a fever, as body temperature can fluctuate throughout the day and can be influenced by various factors such as physical activity, environmental conditions, and the menstrual cycle in females. The diagnosis of fever typically requires the confirmation of an elevated core body temperature on at least two occasions or a consistently high temperature over a period of time.

While fevers are generally considered beneficial in fighting off infections and promoting recovery, extremely high temperatures or prolonged febrile states may necessitate medical intervention to prevent potential complications such as dehydration, seizures, or damage to vital organs.

"Aedes" is a genus of mosquitoes that are known to transmit various diseases, including Zika virus, dengue fever, chikungunya, and yellow fever. These mosquitoes are typically found in tropical and subtropical regions around the world. They are distinguished by their black and white striped legs and thorax. Aedes aegypti is the most common species associated with disease transmission, although other species such as Aedes albopictus can also transmit diseases. It's important to note that only female mosquitoes bite and feed on blood, while males feed solely on nectar and plant juices.

Flavivirus is a genus of viruses in the family Flaviviridae. They are enveloped, single-stranded, positive-sense RNA viruses that are primarily transmitted by arthropod vectors such as mosquitoes and ticks. Many flaviviruses cause significant disease in humans, including dengue fever, yellow fever, Japanese encephalitis, West Nile fever, and Zika fever. The name "flavivirus" is derived from the Latin word for "yellow," referring to the yellow fever virus, which was one of the first members of this genus to be discovered.

"Alouatta" is a genus of species that are commonly known as howler monkeys. They are native to the forests of Central and South America. These monkeys are recognized for their loud howls, which can be heard miles away in the forest. The howls are used to communicate with other members of their group and establish territory. Howler monkeys have a strong grip and spend most of their time in the trees. They are primarily herbivores, eating mostly leaves, fruits, and buds.

Q fever is a zoonotic disease caused by the bacterium Coxiella burnetii. It is characterized by acute or chronic flu-like symptoms, pneumonia, and hepatitis. The bacteria are primarily transmitted to humans through inhalation of contaminated dust or aerosols from infected animals such as cattle, sheep, and goats. Q fever can also be transmitted through consumption of unpasteurized milk or direct contact with infected animals. It is often asymptomatic or mildly symptomatic in animals but can cause severe disease in humans.

The acute form of Q fever typically presents with sudden onset of high fever, severe headache, fatigue, muscle pain, and cough. Some patients may also develop pneumonia or hepatitis. The chronic form of the disease is less common but more serious, often affecting people with compromised immune systems. Chronic Q fever can lead to endocarditis, an infection of the inner lining of the heart, which can be life-threatening if left untreated.

Diagnosis of Q fever typically involves a combination of clinical evaluation, serological testing, and PCR (polymerase chain reaction) assays. Treatment usually involves antibiotics such as doxycycline or fluoroquinolones for several weeks to months, depending on the severity and duration of the illness. Prevention measures include avoiding contact with infected animals, wearing protective clothing and masks when handling animal products, and pasteurizing milk before consumption.

Flavivirus infections refer to a group of diseases caused by various viruses belonging to the Flaviviridae family, specifically within the genus Flavivirus. These viruses are primarily transmitted to humans through the bites of infected arthropods, such as mosquitoes and ticks.

Some well-known flavivirus infections include:

1. Dengue Fever: A mosquito-borne viral infection that is prevalent in tropical and subtropical regions worldwide. It can cause a wide range of symptoms, from mild flu-like illness to severe complications like dengue hemorrhagic fever and dengue shock syndrome.
2. Yellow Fever: A viral hemorrhagic disease transmitted by the Aedes and Haemagogus mosquitoes, primarily in Africa and South America. It can cause severe illness, including jaundice, bleeding, organ failure, and death.
3. Japanese Encephalitis: A mosquito-borne viral infection that is endemic to Southeast Asia and the Western Pacific. While most infections are asymptomatic or mild, a small percentage of cases can lead to severe neurological complications, such as encephalitis (inflammation of the brain) and meningitis (inflammation of the membranes surrounding the brain and spinal cord).
4. Zika Virus Infection: A mosquito-borne viral disease that has spread to many regions of the world, particularly in tropical and subtropical areas. Most Zika virus infections are mild or asymptomatic; however, infection during pregnancy can cause severe birth defects, such as microcephaly (abnormally small head size) and other neurological abnormalities in the developing fetus.
5. West Nile Virus Infection: A mosquito-borne viral disease that is endemic to North America, Europe, Africa, Asia, and Australia. Most infections are mild or asymptomatic; however, a small percentage of cases can lead to severe neurological complications, such as encephalitis, meningitis, and acute flaccid paralysis (sudden weakness in the arms and legs).

Prevention measures for these diseases typically involve avoiding mosquito bites through the use of insect repellent, wearing long sleeves and pants, staying indoors during peak mosquito hours, and removing standing water from around homes and businesses. Additionally, vaccines are available for some of these diseases, such as Japanese encephalitis and yellow fever, and should be considered for individuals traveling to areas where these diseases are common.

Insect vectors are insects that transmit disease-causing pathogens (such as viruses, bacteria, parasites) from one host to another. They do this while feeding on the host's blood or tissues. The insects themselves are not infected by the pathogen but act as mechanical carriers that pass it on during their bite. Examples of diseases spread by insect vectors include malaria (transmitted by mosquitoes), Lyme disease (transmitted by ticks), and plague (transmitted by fleas). Proper prevention measures, such as using insect repellent and reducing standing water where mosquitoes breed, can help reduce the risk of contracting these diseases.

Typhoid fever is an acute illness caused by the bacterium Salmonella enterica serovar Typhi. It is characterized by sustained fever, headache, constipation or diarrhea, rose-colored rash (in some cases), abdominal pain, and weakness. The bacteria are spread through contaminated food, water, or direct contact with an infected person's feces. If left untreated, typhoid fever can lead to severe complications and even be fatal. It is diagnosed through blood, stool, or urine tests and treated with antibiotics. Vaccination is available for prevention.

'Culicidae' is the biological family that includes all species of mosquitoes. It consists of three subfamilies: Anophelinae, Culicinae, and Toxorhynchitinae. Mosquitoes are small, midge-like flies that are known for their ability to transmit various diseases to humans and other animals, such as malaria, yellow fever, dengue fever, and Zika virus. The medical importance of Culicidae comes from the fact that only female mosquitoes require blood meals to lay eggs, and during this process, they can transmit pathogens between hosts.

Dengue virus (DENV) is a single-stranded, positive-sense RNA virus that belongs to the genus Flavivirus in the family Flaviviridae. It is primarily transmitted to humans through the bites of infected female mosquitoes, mainly Aedes aegypti and Aedes albopictus.

The DENV genome contains approximately 11,000 nucleotides and encodes three structural proteins (capsid, pre-membrane/membrane, and envelope) and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5). There are four distinct serotypes of DENV (DENV-1, DENV-2, DENV-3, and DENV-4), each of which can cause dengue fever, a mosquito-borne viral disease.

Infection with one serotype provides lifelong immunity against that particular serotype but only temporary and partial protection against the other three serotypes. Subsequent infections with different serotypes can increase the risk of developing severe dengue, such as dengue hemorrhagic fever or dengue shock syndrome, due to antibody-dependent enhancement (ADE) and original antigenic sin phenomena.

DENV is a significant public health concern in tropical and subtropical regions worldwide, with an estimated 390 million annual infections and approximately 100-400 million clinical cases. Preventive measures include vector control strategies to reduce mosquito populations and the development of effective vaccines against all four serotypes.

Arbovirus infections are a group of diseases caused by viruses that are transmitted to humans through the bites of infected arthropods, such as mosquitoes, ticks, and midges. "Arbo" is short for "arthropod-borne."

There are over 150 different Arboviruses, but only a few cause significant illness in humans. Some of the most common Arbovirus infections include:

* Dengue fever
* Chikungunya fever
* Yellow fever
* Zika virus infection
* Japanese encephalitis
* West Nile fever
* Tick-borne encephalitis

The symptoms of Arbovirus infections can vary widely, depending on the specific virus and the individual infected. Some people may experience only mild illness or no symptoms at all, while others may develop severe, life-threatening complications.

Common symptoms of Arbovirus infections include fever, headache, muscle and joint pain, rash, and fatigue. In more severe cases, Arbovirus infections can cause neurological problems such as meningitis (inflammation of the membranes surrounding the brain and spinal cord) or encephalitis (inflammation of the brain).

There is no specific treatment for most Arbovirus infections. Treatment is generally supportive, with fluids and medications to relieve symptoms. In severe cases, hospitalization may be necessary to manage complications such as dehydration or neurological problems.

Prevention of Arbovirus infections involves avoiding mosquito and tick bites, using insect repellent, wearing protective clothing, and eliminating breeding sites for mosquitoes and ticks. Vaccines are available to prevent some Arbovirus infections, such as yellow fever and Japanese encephalitis.

A viral vaccine is a biological preparation that introduces your body to a specific virus in a way that helps your immune system build up protection against the virus without causing the illness. Viral vaccines can be made from weakened or inactivated forms of the virus, or parts of the virus such as proteins or sugars. Once introduced to the body, the immune system recognizes the virus as foreign and produces an immune response, including the production of antibodies. These antibodies remain in the body and provide immunity against future infection with that specific virus.

Viral vaccines are important tools for preventing infectious diseases caused by viruses, such as influenza, measles, mumps, rubella, polio, hepatitis A and B, rabies, rotavirus, chickenpox, shingles, and some types of cancer. Vaccination programs have led to the control or elimination of many infectious diseases that were once common.

It's important to note that viral vaccines are not effective against bacterial infections, and separate vaccines must be developed for each type of virus. Additionally, because viruses can mutate over time, it is necessary to update some viral vaccines periodically to ensure continued protection.

I'm sorry for any confusion, but "South America" is not a medical term. It is a geographical term that refers to the southern portion of the Americas, which is a continent in the Western Hemisphere. South America is generally defined as including the countries of Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Guyana, Paraguay, Peru, Suriname, Uruguay, and Venezuela, as well as the overseas departments and territories of French Guiana (France), and the Falkland Islands (UK).

If you have any questions related to medical terminology or health-related topics, I would be happy to help answer them for you.

Fever of Unknown Origin (FUO) is a medical condition defined as a fever that remains undiagnosed after one week of inpatient evaluation or three days of outpatient evaluation, with temperatures repeatedly measuring at or above 38.3°C (101°F). The fevers can be continuous or intermittent and are often associated with symptoms such as fatigue, weight loss, and general malaise.

The causes of FUO can be broadly categorized into four groups: infections, inflammatory diseases, neoplasms (cancers), and miscellaneous conditions. Infections account for a significant proportion of cases, particularly in immunocompromised individuals. Other possible causes include connective tissue disorders, vasculitides, drug reactions, and factitious fever.

The diagnostic approach to FUO involves a thorough history and physical examination, laboratory tests, and imaging studies. The goal is to identify the underlying cause of the fever and provide appropriate treatment. In some cases, despite extensive evaluation, the cause may remain undiagnosed, and management focuses on supportive care and monitoring for any new symptoms or complications.

**Hemorrhagic fevers, viral** are a group of severe, potentially fatal illnesses caused by viruses that affect the body's ability to regulate its blood vessels and clotting abilities. These viruses belong to several different families including *Filoviridae* (e.g., Ebola, Marburg), *Arenaviridae* (e.g., Lassa, Machupo), *Bunyaviridae* (e.g., Hantavirus, Crimean-Congo hemorrhagic fever virus) and *Flaviviridae* (e.g., Dengue, Yellow Fever).

The initial symptoms are non-specific and include sudden onset of fever, fatigue, muscle aches, joint pains, headache, and vomiting. As the disease progresses, it may lead to capillary leakage, internal and external bleeding, and multi-organ failure resulting in shock and death in severe cases.

The transmission of these viruses can occur through various means depending on the specific virus. For example, some are transmitted via contact with infected animals or their urine/feces (e.g., Hantavirus), others through insect vectors like ticks (Crimean-Congo hemorrhagic fever) or mosquitoes (Dengue, Yellow Fever), and yet others through direct contact with infected body fluids (Ebola, Marburg).

There are no specific treatments for most viral hemorrhagic fevers. However, some experimental antiviral drugs have shown promise in treating certain types of the disease. Supportive care, such as maintaining blood pressure, replacing lost fluids and electrolytes, and managing pain, is critical to improving outcomes. Prevention measures include avoiding areas where the viruses are common, using personal protective equipment when caring for infected individuals or handling potentially contaminated materials, and controlling insect vectors.

Sources: Centers for Disease Control and Prevention (CDC), World Health Organization (WHO).

Arboviruses are a group of viruses that are primarily transmitted to humans and animals through the bites of infected arthropods, such as mosquitoes, ticks, and sandflies. The term "arbovirus" is short for "arthropod-borne virus."

Arboviruses can cause a wide range of symptoms, depending on the specific virus and the individual host's immune response. Some common symptoms associated with arboviral infections include fever, headache, muscle and joint pain, rash, and fatigue. In severe cases, arboviral infections can lead to serious complications such as encephalitis (inflammation of the brain), meningitis (inflammation of the membranes surrounding the brain and spinal cord), or hemorrhagic fever (bleeding disorders).

There are hundreds of different arboviruses, and they are found in many parts of the world. Some of the most well-known arboviral diseases include dengue fever, chikungunya, Zika virus infection, West Nile virus infection, yellow fever, and Japanese encephalitis.

Prevention of arboviral infections typically involves avoiding mosquito bites and other arthropod vectors through the use of insect repellent, wearing long sleeves and pants, and staying indoors during peak mosquito feeding times. Public health efforts also focus on reducing vector populations through environmental management and the use of larvicides. Vaccines are available for some arboviral diseases, such as yellow fever and Japanese encephalitis.

Travel medicine, also known as tropical medicine or geographic medicine, is a branch of medicine that deals with the prevention and management of health issues and diseases that can occur during international travel or in certain geographical areas. This may include vaccinations, malaria prophylaxis, advice on food and water safety, and education about insect-borne diseases. Travel medicine specialists also provide care for travelers who become ill while abroad and offer post-travel evaluation and treatment for those who return home with a travel-related illness.

Antibodies, viral are proteins produced by the immune system in response to an infection with a virus. These antibodies are capable of recognizing and binding to specific antigens on the surface of the virus, which helps to neutralize or destroy the virus and prevent its replication. Once produced, these antibodies can provide immunity against future infections with the same virus.

Viral antibodies are typically composed of four polypeptide chains - two heavy chains and two light chains - that are held together by disulfide bonds. The binding site for the antigen is located at the tip of the Y-shaped structure, formed by the variable regions of the heavy and light chains.

There are five classes of antibodies in humans: IgA, IgD, IgE, IgG, and IgM. Each class has a different function and is distributed differently throughout the body. For example, IgG is the most common type of antibody found in the bloodstream and provides long-term immunity against viruses, while IgA is found primarily in mucous membranes and helps to protect against respiratory and gastrointestinal infections.

In addition to their role in the immune response, viral antibodies can also be used as diagnostic tools to detect the presence of a specific virus in a patient's blood or other bodily fluids.

Dengue is a mosquito-borne viral infection that is primarily transmitted by the Aedes aegypti and Aedes albopictus species of mosquitoes. It is caused by one of four closely related dengue viruses (DENV 1, DENV 2, DENV 3, or DENV 4). The infection can cause a wide range of symptoms, ranging from mild fever and headache to severe flu-like illness, which is often characterized by the sudden onset of high fever, severe headache, muscle and joint pain, nausea, vomiting, and skin rash. In some cases, dengue can progress to more severe forms, such as dengue hemorrhagic fever or dengue shock syndrome, which can be life-threatening if not treated promptly and appropriately.

Dengue is prevalent in many tropical and subtropical regions around the world, particularly in urban and semi-urban areas with poor sanitation and inadequate mosquito control. There is no specific treatment for dengue, and prevention efforts focus on reducing mosquito populations and avoiding mosquito bites. Vaccines are available in some countries to prevent dengue infection, but they are not widely used due to limitations in their effectiveness and safety.

Vero cells are a line of cultured kidney epithelial cells that were isolated from an African green monkey (Cercopithecus aethiops) in the 1960s. They are named after the location where they were initially developed, the Vervet Research Institute in Japan.

Vero cells have the ability to divide indefinitely under certain laboratory conditions and are often used in scientific research, including virology, as a host cell for viruses to replicate. This allows researchers to study the characteristics of various viruses, such as their growth patterns and interactions with host cells. Vero cells are also used in the production of some vaccines, including those for rabies, polio, and Japanese encephalitis.

It is important to note that while Vero cells have been widely used in research and vaccine production, they can still have variations between different cell lines due to factors like passage number or culture conditions. Therefore, it's essential to specify the exact source and condition of Vero cells when reporting experimental results.

West Nile Virus (WNV) vaccines are immunizations that are designed to protect against the West Nile virus, which is a single-stranded RNA virus that belongs to the family Flaviviridae. The virus is primarily transmitted to humans through the bite of infected mosquitoes, particularly those of the Culex species.

There are currently no licensed WNV vaccines available for human use in the United States or Europe. However, there are several veterinary vaccines that have been developed and approved for use in horses and other animals, such as birds and geese. These vaccines work by stimulating the immune system to produce antibodies against the virus, which can help prevent infection and reduce the severity of symptoms in animals that do become infected.

Human WNV vaccine candidates are in various stages of development and testing. Some of these vaccines use inactivated or weakened forms of the virus, while others use only a portion of the viral protein to stimulate an immune response. While these vaccines have shown promise in clinical trials, further research is needed to determine their safety and effectiveness in larger populations before they can be approved for widespread use.

Rheumatic fever is a systemic inflammatory disease that may occur following an untreated Group A streptococcal infection, such as strep throat. It primarily affects children between the ages of 5 and 15, but it can occur at any age. The condition is characterized by inflammation in various parts of the body, including the heart (carditis), joints (arthritis), skin (erythema marginatum, subcutaneous nodules), and brain (Sydenham's chorea).

The onset of rheumatic fever usually occurs 2-4 weeks after a streptococcal infection. The exact cause of the immune system's overreaction leading to rheumatic fever is not fully understood, but it involves molecular mimicry between streptococcal antigens and host tissues.

The Jones Criteria are used to diagnose rheumatic fever, which include:

1. Evidence of a preceding streptococcal infection (e.g., positive throat culture or rapid strep test, elevated or rising anti-streptolysin O titer)
2. Carditis (heart inflammation), including new murmurs or changes in existing murmurs, electrocardiogram abnormalities, or evidence of heart failure
3. Polyarthritis (inflammation of multiple joints) – typically large joints like the knees and ankles, migratory, and may be associated with warmth, swelling, and pain
4. Erythema marginatum (a skin rash characterized by pink or red, irregularly shaped macules or rings that blanch in the center and spread outward)
5. Subcutaneous nodules (firm, round, mobile lumps under the skin, usually over bony prominences)
6. Sydenham's chorea (involuntary, rapid, irregular movements, often affecting the face, hands, and feet)

Treatment of rheumatic fever typically involves antibiotics to eliminate any residual streptococcal infection, anti-inflammatory medications like corticosteroids or nonsteroidal anti-inflammatory drugs (NSAIDs) to manage symptoms and prevent long-term heart complications, and secondary prophylaxis with regular antibiotic administration to prevent recurrent streptococcal infections.

Malpighian tubules are specialized excretory structures found in the circulatory system of many arthropods, including insects. They are named after Marcello Malpighi, an Italian physician and biologist who was one of the first to describe them. These tubules play a crucial role in eliminating waste products and maintaining water and ion balance within the insect's body.

Functionally, Malpighian tubules are analogous to the vertebrate kidneys as they filter the hemolymph (insect blood) and reabsorb necessary substances while excreting waste materials. The main waste product excreted by these tubules is uric acid, which is a less toxic form of nitrogenous waste compared to urea or ammonia, making it more suitable for terrestrial arthropods.

Malpighian tubules originate from the midgut epithelium and extend into the hemocoel (insect body cavity). They are lined with a single layer of epithelial cells that contain microvilli, increasing their surface area for efficient filtration. The tubules receive nutrient-rich hemolymph from the hemocoel through open-ended or blind-ended structures called ostia.

The filtrate formed by Malpighian tubules passes through a series of cellular transport processes involving both active and passive transport mechanisms. These processes help in reabsorbing water, ions, and nutrients back into the hemolymph while concentrating waste products for excretion. The final waste-laden fluid is then released into the hindgut, where it gets mixed with fecal material before being eliminated from the body through the anus.

In summary, Malpighian tubules are vital excretory organs in arthropods that filter hemolymph, reabsorb essential substances, and excrete waste products to maintain homeostasis within their bodies.

I'm sorry for any confusion, but "travel" is not a term that has a specific medical definition. In general, travel refers to the act of moving or journeying from one place to another, often over long distances. However, in a medical context, it might refer to the recommendation that individuals with certain medical conditions or those who are immunocompromised avoid traveling to areas where they may be at increased risk of exposure to infectious diseases. It's always best to check with a healthcare professional for advice related to specific medical situations and travel.

Viral nonstructural proteins (NS) are viral proteins that are not part of the virion structure. They play various roles in the viral life cycle, such as replication of the viral genome, transcription, translation regulation, and modulation of the host cell environment to favor virus replication. These proteins are often produced in large quantities during infection and can manipulate or disrupt various cellular pathways to benefit the virus. They may also be involved in evasion of the host's immune response. The specific functions of viral nonstructural proteins vary depending on the type of virus.

Attenuated vaccines consist of live microorganisms that have been weakened (attenuated) through various laboratory processes so they do not cause disease in the majority of recipients but still stimulate an immune response. The purpose of attenuation is to reduce the virulence or replication capacity of the pathogen while keeping it alive, allowing it to retain its antigenic properties and induce a strong and protective immune response.

Examples of attenuated vaccines include:

1. Sabin oral poliovirus vaccine (OPV): This vaccine uses live but weakened polioviruses to protect against all three strains of the disease-causing poliovirus. The weakened viruses replicate in the intestine and induce an immune response, which provides both humoral (antibody) and cell-mediated immunity.
2. Measles, mumps, and rubella (MMR) vaccine: This combination vaccine contains live attenuated measles, mumps, and rubella viruses. It is given to protect against these three diseases and prevent their spread in the population.
3. Varicella (chickenpox) vaccine: This vaccine uses a weakened form of the varicella-zoster virus, which causes chickenpox. By introducing this attenuated virus into the body, it stimulates an immune response that protects against future infection with the wild-type virus.
4. Yellow fever vaccine: This live attenuated vaccine is used to prevent yellow fever, a viral disease transmitted by mosquitoes in tropical and subtropical regions of Africa and South America. The vaccine contains a weakened form of the yellow fever virus that cannot cause the disease but still induces an immune response.
5. Bacillus Calmette-Guérin (BCG) vaccine: This live attenuated vaccine is used to protect against tuberculosis (TB). It contains a weakened strain of Mycobacterium bovis, which does not cause TB in humans but stimulates an immune response that provides some protection against the disease.

Attenuated vaccines are generally effective at inducing long-lasting immunity and can provide robust protection against targeted diseases. However, they may pose a risk for individuals with weakened immune systems, as the attenuated viruses or bacteria could potentially cause illness in these individuals. Therefore, it is essential to consider an individual's health status before administering live attenuated vaccines.

'Cercopithecus aethiops' is the scientific name for the monkey species more commonly known as the green monkey. It belongs to the family Cercopithecidae and is native to western Africa. The green monkey is omnivorous, with a diet that includes fruits, nuts, seeds, insects, and small vertebrates. They are known for their distinctive greenish-brown fur and long tail. Green monkeys are also important animal models in biomedical research due to their susceptibility to certain diseases, such as SIV (simian immunodeficiency virus), which is closely related to HIV.

Rift Valley Fever (RVF) is a viral zoonotic disease that primarily affects animals, but can also have serious consequences for humans. It is caused by the Rift Valley Fever virus (RVFV), which belongs to the family Bunyaviridae and the genus Phlebovirus.

The disease is transmitted through the bite of infected mosquitoes or through contact with the blood, milk, or other bodily fluids of infected animals such as cattle, sheep, goats, and camels. In humans, RVF can cause a range of symptoms, from mild fever and headache to severe complications such as retinitis, encephalitis, and hemorrhagic fever, which can be fatal in some cases.

RVF is endemic in parts of Africa, particularly in the Rift Valley region, and has also been reported in the Arabian Peninsula. It poses a significant public health and economic threat to affected regions due to its potential to cause large-scale outbreaks with high mortality rates in both animals and humans. Prevention and control measures include vaccination of animals, vector control, and avoidance of mosquito bites.

A disease outbreak is defined as the occurrence of cases of a disease in excess of what would normally be expected in a given time and place. It may affect a small and localized group or a large number of people spread over a wide area, even internationally. An outbreak may be caused by a new agent, a change in the agent's virulence or host susceptibility, or an increase in the size or density of the host population.

Outbreaks can have significant public health and economic impacts, and require prompt investigation and control measures to prevent further spread of the disease. The investigation typically involves identifying the source of the outbreak, determining the mode of transmission, and implementing measures to interrupt the chain of infection. This may include vaccination, isolation or quarantine, and education of the public about the risks and prevention strategies.

Examples of disease outbreaks include foodborne illnesses linked to contaminated food or water, respiratory infections spread through coughing and sneezing, and mosquito-borne diseases such as Zika virus and West Nile virus. Outbreaks can also occur in healthcare settings, such as hospitals and nursing homes, where vulnerable populations may be at increased risk of infection.

Lassa fever is an acute viral hemorrhagic fever caused by the Lassa virus. It is primarily transmitted to humans through contact with infected rodents or their excreta, and it can also spread from person to person via bodily fluids. The symptoms of Lassa fever typically include fever, sore throat, muscle pain, chest pain, headache, and vomiting. In severe cases, the disease can cause bleeding from the mouth and nose, as well as complications such as deafness and encephalitis. Lassa fever is endemic to West Africa, particularly in Nigeria, Guinea, Liberia, and Sierra Leone.

Neutralization tests are a type of laboratory assay used in microbiology and immunology to measure the ability of a substance, such as an antibody or antitoxin, to neutralize the activity of a toxin or infectious agent. In these tests, the substance to be tested is mixed with a known quantity of the toxin or infectious agent, and the mixture is then incubated under controlled conditions. After incubation, the mixture is tested for residual toxicity or infectivity using a variety of methods, such as cell culture assays, animal models, or biochemical assays.

The neutralization titer is then calculated based on the highest dilution of the test substance that completely neutralizes the toxin or infectious agent. Neutralization tests are commonly used in the diagnosis and evaluation of immune responses to vaccines, as well as in the detection and quantification of toxins and other harmful substances.

Examples of neutralization tests include the serum neutralization test for measles antibodies, the plaque reduction neutralization test (PRNT) for dengue virus antibodies, and the cytotoxicity neutralization assay for botulinum neurotoxins.

Viral envelope proteins are structural proteins found in the envelope that surrounds many types of viruses. These proteins play a crucial role in the virus's life cycle, including attachment to host cells, fusion with the cell membrane, and entry into the host cell. They are typically made up of glycoproteins and are often responsible for eliciting an immune response in the host organism. The exact structure and function of viral envelope proteins vary between different types of viruses.

I'm sorry for any confusion, but "Insect Proteins" is not a recognized medical term. However, I can provide some information about insect protein from a nutritional and food science perspective.

Insect proteins refer to the proteins that are obtained from insects. Insects are a rich source of protein, and their protein content varies by species. For example, mealworms and crickets have been found to contain approximately 47-63% and 60-72% protein by dry weight, respectively.

In recent years, insect proteins have gained attention as a potential sustainable source of nutrition due to their high protein content, low environmental impact, and the ability to convert feed into protein more efficiently compared to traditional livestock. Insect proteins can be used in various applications such as food and feed additives, nutritional supplements, and even cosmetics.

However, it's important to note that the use of insect proteins in human food is not widely accepted in many Western countries due to cultural and regulatory barriers. Nonetheless, research and development efforts continue to explore the potential benefits and applications of insect proteins in the global food system.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

Vaccination is a simple, safe, and effective way to protect people against harmful diseases, before they come into contact with them. It uses your body's natural defenses to build protection to specific infections and makes your immune system stronger.

A vaccination usually contains a small, harmless piece of a virus or bacteria (or toxins produced by these germs) that has been made inactive or weakened so it won't cause the disease itself. This piece of the germ is known as an antigen. When the vaccine is introduced into the body, the immune system recognizes the antigen as foreign and produces antibodies to fight it.

If a person then comes into contact with the actual disease-causing germ, their immune system will recognize it and immediately produce antibodies to destroy it. The person is therefore protected against that disease. This is known as active immunity.

Vaccinations are important for both individual and public health. They prevent the spread of contagious diseases and protect vulnerable members of the population, such as young children, the elderly, and people with weakened immune systems who cannot be vaccinated or for whom vaccination is not effective.

I apologize, but "Brazil" is not a medical term or condition. It is the largest country in both South America and Latin America by land area and population. If you have any questions related to medical terminology or health concerns, please provide more information and I will do my best to help.

Central America is a geographical region that connects North America and South America. It is made up of seven countries: Belize, Guatemala, Honduras, El Salvador, Nicaragua, Costa Rica, and Panama. The eastern coast of Central America is bordered by the Caribbean Sea, while the western coast is bordered by the Pacific Ocean.

The region is characterized by its diverse geography, which includes lowland rainforests, volcanic mountain ranges, and coastal plains. It is also home to a wide range of plant and animal species, many of which are found nowhere else in the world.

Culturally, Central America is a melting pot of indigenous, African, and European influences. The region has a rich history of Mayan civilization, as well as Spanish colonialism. Today, the countries of Central America have diverse economies, with agriculture, manufacturing, and tourism being major industries.

"History, 19th Century" is not a medical term or concept. It refers to the historical events, developments, and figures related to the 1800s in various fields, including politics, culture, science, and technology. However, if you are looking for medical advancements during the 19th century, here's a brief overview:

The 19th century was a period of significant progress in medicine, with numerous discoveries and innovations that shaped modern medical practices. Some notable developments include:

1. Edward Jenner's smallpox vaccine (1796): Although not strictly within the 19th century, Jenner's discovery laid the foundation for vaccination as a preventive measure against infectious diseases.
2. Germ theory of disease: The work of Louis Pasteur, Robert Koch, and others established that many diseases were caused by microorganisms, leading to the development of antiseptic practices and vaccines.
3. Anesthesia: In 1842, Crawford Long first used ether as an anesthetic during surgery, followed by the introduction of chloroform in 1847 by James Simpson.
4. Antisepsis and asepsis: Joseph Lister introduced antiseptic practices in surgery, significantly reducing postoperative infections. Later, the concept of asepsis (sterilization) was developed to prevent contamination during surgical procedures.
5. Microbiology: The development of techniques for culturing and staining bacteria allowed for better understanding and identification of pathogens.
6. Physiology: Claude Bernard's work on the regulation of internal body functions, or homeostasis, contributed significantly to our understanding of human physiology.
7. Neurology: Jean-Martin Charcot made significant contributions to the study of neurological disorders, including multiple sclerosis and Parkinson's disease.
8. Psychiatry: Sigmund Freud developed psychoanalysis, a new approach to understanding mental illnesses.
9. Public health: The 19th century saw the establishment of public health organizations and initiatives aimed at improving sanitation, water quality, and vaccination programs.
10. Medical education reforms: The Flexner Report in 1910 led to significant improvements in medical education standards and practices.

A viral plaque assay is a laboratory technique used to measure the infectivity and concentration of viruses in a sample. This method involves infecting a monolayer of cells (usually in a petri dish or multi-well plate) with a known volume of a virus-containing sample, followed by overlaying the cells with a nutrient-agar medium to restrict viral spread and enable individual plaques to form.

After an incubation period that allows for viral replication and cell death, the cells are stained, and clear areas or "plaques" become visible in the monolayer. Each plaque represents a localized region of infected and lysed cells, caused by the progeny of a single infectious virus particle. The number of plaques is then counted, and the viral titer (infectious units per milliliter or PFU/mL) is calculated based on the dilution factor and volume of the original inoculum.

Viral plaque assays are essential for determining viral titers, assessing virus-host interactions, evaluating antiviral agents, and studying viral pathogenesis.

Crimean hemorrhagic fever (CHF) is a tick-borne disease caused by the virus named Crimean-Congo hemorrhagic fever virus (CCHFV). It is a severe and often fatal illness. The disease is characterized by sudden onset of high fever, muscle pain, severe headache, soreness in the eyes, fatigue, and dizziness. After two to four days, there may be evidence of hemorrhage (bleeding) from the mouth, gums, nose, or other sites. The virus is primarily transmitted to people from ticks that feed on domestic animals such as cattle, sheep, and goats. It can also be transmitted through contact with infected animal blood or tissues during and after slaughtering. Human-to-human transmission can occur resulting from close contact with the blood, secretions, organs or other bodily fluids of infected persons. Healthcare workers are at risk if they are not wearing appropriate personal protective equipment. There is no specific treatment for CHF yet, but early supportive care and symptomatic treatment improve survival rates.

A disease vector is a living organism that transmits infectious pathogens from one host to another. These vectors can include mosquitoes, ticks, fleas, and other arthropods that carry viruses, bacteria, parasites, or other disease-causing agents. The vector becomes infected with the pathogen after biting an infected host, and then transmits the infection to another host through its saliva or feces during a subsequent blood meal.

Disease vectors are of particular concern in public health because they can spread diseases rapidly and efficiently, often over large geographic areas. Controlling vector-borne diseases requires a multifaceted approach that includes reducing vector populations, preventing bites, and developing vaccines or treatments for the associated diseases.

Hemagglutination inhibition (HI) tests are a type of serological assay used in medical laboratories to detect and measure the amount of antibodies present in a patient's serum. These tests are commonly used to diagnose viral infections, such as influenza or HIV, by identifying the presence of antibodies that bind to specific viral antigens and prevent hemagglutination (the agglutination or clumping together of red blood cells).

In an HI test, a small amount of the patient's serum is mixed with a known quantity of the viral antigen, which has been treated to attach to red blood cells. If the patient's serum contains antibodies that bind to the viral antigen, they will prevent the antigen from attaching to the red blood cells and inhibit hemagglutination. The degree of hemagglutination inhibition can be measured and used to estimate the amount of antibody present in the patient's serum.

HI tests are relatively simple and inexpensive to perform, but they have some limitations. For example, they may not detect early-stage infections before the body has had a chance to produce antibodies, and they may not be able to distinguish between different strains of the same virus. Nonetheless, HI tests remain an important tool for diagnosing viral infections and monitoring immune responses to vaccination or infection.

A viral RNA (ribonucleic acid) is the genetic material found in certain types of viruses, as opposed to viruses that contain DNA (deoxyribonucleic acid). These viruses are known as RNA viruses. The RNA can be single-stranded or double-stranded and can exist as several different forms, such as positive-sense, negative-sense, or ambisense RNA. Upon infecting a host cell, the viral RNA uses the host's cellular machinery to translate the genetic information into proteins, leading to the production of new virus particles and the continuation of the viral life cycle. Examples of human diseases caused by RNA viruses include influenza, COVID-19 (SARS-CoV-2), hepatitis C, and polio.

I'm sorry for any confusion, but the term "Africa" actually refers to a continent, not a medical condition or concept. Africa is the second-largest continent in the world, consisting of 54 countries and a wide range of diverse ethnic groups, cultures, languages, and landscapes. It is home to a vast array of wildlife, including many species that are not found anywhere else in the world. If you have any questions about Africa's geography, history, or culture, I would be happy to try to help answer them!

Boutonneuse fever, also known as Mediterranean spotted fever, is a tick-borne disease caused by the bacterium Rickettsia conorii. The name "boutonneuse" comes from the French word for "button-like," which refers to the characteristic eschar (a black scab) that often develops at the site of the tick bite.

The symptoms of boutonneuse fever typically appear within 1-2 weeks after a tick bite and include fever, headache, muscle pain, and fatigue. A rash may also develop, starting on the limbs and spreading to the trunk, which can help distinguish this disease from other tick-borne illnesses.

If left untreated, boutonneuse fever can be serious or even fatal, so it is important to seek medical attention if you suspect that you have been bitten by a tick and are experiencing symptoms of the disease. Treatment typically involves antibiotics such as doxycycline, which can help reduce the severity of symptoms and prevent complications.

Phylogeny is the evolutionary history and relationship among biological entities, such as species or genes, based on their shared characteristics. In other words, it refers to the branching pattern of evolution that shows how various organisms have descended from a common ancestor over time. Phylogenetic analysis involves constructing a tree-like diagram called a phylogenetic tree, which depicts the inferred evolutionary relationships among organisms or genes based on molecular sequence data or other types of characters. This information is crucial for understanding the diversity and distribution of life on Earth, as well as for studying the emergence and spread of diseases.

Emerging communicable diseases are infections whose incidence has increased in the past two decades or threatens to increase in the near future. These diseases can be caused by new microbial agents, or by previously known agents that have newly acquired the ability to cause disease in humans. They may also result from changes in human demographics, behavior, or travel patterns, or from technological or environmental changes. Examples of emerging communicable diseases include COVID-19, Ebola virus disease, Zika virus infection, and West Nile fever.

Hemorrhagic Fever with Renal Syndrome (HFRS) is a group of clinically similar diseases caused by several distinct but related orthohantaviruses. The viruses are primarily transmitted to humans through inhalation of aerosols contaminated with excreta of infected rodents.

The clinical presentation of HFRS includes four phases: febrile, hypotensive, oliguric (decreased urine output), and polyuric (increased urine output). The febrile phase is characterized by fever, headache, myalgia, and abdominal pain. In the hypotensive phase, patients may experience a sudden drop in blood pressure, shock, and acute kidney injury leading to oliguria. The oliguric phase can last for days to weeks, followed by a polyuric phase where urine output increases significantly.

Additional symptoms of HFRS may include nausea, vomiting, conjunctival injection (redness), photophobia (sensitivity to light), and petechial rash (small red or purple spots on the skin caused by bleeding under the skin). In severe cases, HFRS can lead to acute renal failure, hypovolemic shock, and even death.

The severity of HFRS varies depending on the specific virus causing the infection. The most severe form of HFRS is caused by the Hantaaan virus, which has a mortality rate of up to 15%. Other viruses that can cause HFRS include Dobrava-Belgrade, Seoul, and Puumala viruses, with lower mortality rates ranging from less than 1% to about 5%.

Prevention measures for HFRS include reducing exposure to rodents and their excreta through proper food storage, waste disposal, and rodent control. Vaccines are available in some countries to prevent HFRS caused by specific viruses.

I'm sorry for any confusion, but the term "photoreceptors" is typically used in the context of vision and refers to specialized cells in the retina that convert light into electrical signals. These are found in animals, including humans.

On the other hand, "microbial" generally refers to organisms that are too small to be seen with the naked eye, such as bacteria, archaea, and some types of fungi and algae.

There isn't a widely accepted medical or scientific definition for "photoreceptors, microbial." However, it is known that some microorganisms can respond to light, although they do not have specialized cells like animal photoreceptors. Instead, they may use light-sensitive pigments to detect and respond to light. For example, certain bacteria contain a pigment called bacteriorhodopsin, which they use for light-driven ion transport across their membranes.

Therefore, if you're looking for information on how microorganisms respond to light, it would be more appropriate to search for "microbial photobiology" or "microbial phototaxis."

"Yellow Fever: Practice Essentials, Background, Etiology". Medscape. "Yellow fever fact sheet". WHO-Yellow fever. Archived from ... Yellow fever is caused by Yellow fever virus (YFV), an enveloped RNA virus 40-50 nm in width, the type species and namesake of ... In 1927, yellow fever virus was the first human virus to be isolated. Yellow fever begins after an incubation period of three ... Yellow fever virus is mainly transmitted through the bite of the yellow fever mosquito Aedes aegypti, but other mostly Aedes ...
... is a vaccine that protects against yellow fever. Yellow fever is a viral infection that occurs in Africa ... Demand for the yellow fever vaccine has continued to increase due to the growing number of countries implementing yellow fever ... Since yellow fever vaccination began in the 1930s, only 12 known cases of yellow fever post-vaccination have been identified, ... Yellow Fever Vaccine at the U.S. National Library of Medicine Medical Subject Headings (MeSH) "Yellow Fever Vaccine". Drug ...
Yellow fever may also refer to: Yellow Fever (album), a 1975 blues-rock album by Hot Tuna Yellow Fever!, a 2006 Latin- ... Look up yellow fever in Wiktionary, the free dictionary. Yellow fever is an acute viral hemorrhagic disease. ... "Yellow Fever", a song by Bloodhound Gang from their 1996 album One Fierce Beer Coaster "Yellow Fever", a song by Fela Kuti The ... "Yellow Fever" (Supernatural), an episode of the television series Supernatural The Yellow Fever, a fan club for New Zealand ...
Yellow Fever is the sixth album by the American blues rock band Hot Tuna, recorded and released in 1975 as Grunt BFL1-1238. The ... Altman, Billy (2011). "Hot Tuna: Yellow Fever : Music Reviews : Rolling Stone". Rolling Stone. Archived from the original on ... "Yellow Fever - Hot Tuna , AllMusic". allmusic.com. Retrieved 17 August 2011. Christgau, Robert (1981). "Consumer Guide '70s: H ...
The Yellow Fever Commission was a research team of the United States Army which researched treatment for yellow fever. The ... The 1934 Yellow Jack theatrical production told the story of Walter Reed in the Yellow Fever Commission. The theatre production ... Gamgee, John (1879). "Yellow Fever, A Nautical Disease; Its Origin and Prevention". Internet Archive. New York, New York: ... Augustus (1860). "Yellow Fever : Its Origin, Improper Treatment, Prevention and Cure : With Remarks Regarding Alive-Burials in ...
Yellow Fever is a play by R. A. Shiomi, which takes place on Powell Street in Japantown, Vancouver, a gathering place for the ... "Yellow fever." The New York Times 132 (2 December 1982): 24(N) pC21(L). General Reference Center Gold. Gale. Oliver, Edith. " ... www.nytimes.com/1982/12/02/theater/theater-yellow-fever-by-the-pan-asian-rep.html (Use Canadian English from December 2014, All ...
... who had apparently been killed by yellow fever. Yellow fever killed over 500 in Galveston, Texas, in 1853. It arrived in ... There are a number of 1853 yellow fever victims in the Old Town Key West Cemetery. The fever was at Port Royal, Jamaica in ... Sadler, Elizabeth A. (May 2013). "YELLOW PLAGUE: YELLOW FEVER IN NATCHEZ 1853-1855". California State University Northridge. ... "The Yellow Pestilence: A Comparative Study of the 1853 Yellow Fever Epidemic in New Orleans and the Galveston, Texas Scourge of ...
... "yellow fever" appears on p. 186. On p. 188, Mitchell mentions "… the distemper was what is generally called the yellow fever in ... yellow fever. The yellow fever epidemic of 1793 struck during the summer in Philadelphia, Pennsylvania, where the highest ... Yellow fever epidemics in New Orleans" at The Times-Picayune; updated 27 September 2013, accessed 31 October 2015. Great Yellow ... Yellow fever was a threat in New Orleans and south Louisiana virtually every year, during the warmest months. Among the more ...
... making yellow fever a national crisis. New York doctors finally admitted that they had had an outbreak of yellow fever in 1791 ... made yellow fever a national crisis. As Thomas A. Apel has written "Yellow fever constituted the most pressing national problem ... "A Short History of Yellow Fever in the US". Benjamin Rush, yellow Fever and the Birth of Modern Medicine. Archived from the ... a doctor's apprentice during the city's 1762 Yellow Fever epidemic, saw the pattern; he recognized that yellow fever had ...
The Yellow Fever in Buenos Aires was a series of epidemics that took place in 1852, 1858, 1870 and 1871, the latter being a ... The Yellow Fever would have come from Asunción, Paraguay, brought by Argentine soldiers returning from the war just fought in ... "The Yellow Fever Outbreak of 1871". Retrieved 12 May 2020. cifras extraídas de Buenos Aires: Sencilla Historia, La Trinidad, ... One of the inscriptions there reads: The people of Buenos Aires who fell victim due to the yellow fever epidemic of 1871. ...
Yellow Fever! at AllMusic. Retrieved September 27, 2011. Burns, Todd (June 23, 2006). "Señor Coconut and his Orchestra - Yellow ... Yellow Fever! is a 2006 tribute album by Señor Coconut Y Su Conjunto (Uwe Schmidt). It is an album of covers done in a Latin ... It is a tribute album dedicated to the Yellow Magic Orchestra, and is similar to his earlier Kraftwerk tribute album released ... "My Name Is Coco (Introduction)" - 0:20 "Yellow Magic (Tong Poo)" [Rumba] "Coco Agogo" - 0:36 "Limbo" [Mambo] - 3:21 "What Is a ...
The yellow fever was brought to the city by a ship that had arrived from Cuba. The yellow fever epidemic occurred during late ... Yellow fever was one of the diseases the people of Barcelona suffered from due to such contact. The yellow fever virus is ... The 1870 Barcelona yellow fever epidemic was an epidemic that took place in the Spanish city of Barcelona in 1870. In the late ... These mosquitoes are said to be great carriers of the yellow fever virus and have led to larger outbreaks throughout other ...
In late 2012, a yellow fever outbreak occurred in the Darfur region of Sudan that was the largest yellow fever epidemic to ... "PRO/AH/EDR> Yellow fever - Africa (22): Sudan (Darfur) 2012-11-23 08:15:02 Archive Number: 20121123.1420747". "Yellow fever ... Yellow fever - Africa (12): Sudan (Darfur) 2013-03-02 15:02:44 Archive Number: 20130302.1567578". "PRO/AH/EDR> Yellow fever - ... "Yellow fever". Journal of Clinical Virology. 64: 160-73. doi:10.1016/j.jcv.2014.08.030. PMID 25453327. S2CID 5124080. "Yellow ...
... died of yellow fever in 1878 at the age of 38 in Rio de Janeiro. Jack London, may have contracted yellow fever and other ... died of yellow fever in 1863. Thomas Dundas (British Army officer), Governor of Guadeloupe, died of yellow fever in 1794. John ... Yellow fever, Lists of people by medical condition, Deaths from yellow fever). ... Richard Bayley, physician, died in 1801 of yellow fever caught while inspecting a ship that had arrived in New York City from ...
Keating, J.M. (1879). history of the yellow fever: the yellow fever epidemic of 1878, in Memphis, Tenn. Memphis: Howard ... "Report of the Yellow Fever Epidemic of 1873" (PDF). Louisiana Equitable Life Insurance Company. Ellis, John H. (1992). Yellow ... Ellis, John (1992). Yellow Fever and Public Health in the New South. Lexington, Kentucky: The University Press of Kentucky. p. ... Following the yellow fever epidemic in Shreveport, Louisiana, where 769 people died between August and November, the states in ...
"A yellow fever epidemic has broken out in the Congo". Business Insider. Retrieved 22 June 2016. "Yellow fever situation report ... The case was the first imported yellow fever case in China in history. Yellow fever has never appeared in Asia even though the ... "Yellow fever". World Health Organization. Archived from the original on May 1, 2016. Retrieved 8 May 2016. "Yellow fever - ... "Yellow Fever: Southeast Asia's next great outbreak? , GovInsider". 4 July 2016. Retrieved 4 July 2016. "Yellow fever virus in ...
"Chapter 5 - dengue fever (DF) and dengue hemorrhagic fever (DHF)". 2010 Yellow Book. Archived from the original on 29 December ... The 1997 classification divided dengue into an undifferentiated fever, dengue fever, and dengue hemorrhagic fever. Dengue ... viral hemorrhagic fever, typhoid fever, meningococcal disease, measles, and influenza. Zika fever also has similar symptoms as ... It is based on a weakened combination of the yellow fever virus and each of the four dengue serotypes. Studies of the vaccine ...
... yellow fever, and two viruses in the tick-borne encephalitis group that cause VHF: Omsk hemorrhagic fever virus and Kyasanur ... The Great Yellow Fever Epidemic of 1793 in Philadelphia, PA, US. Nearly 10% of the population of 50,000 died from the disease. ... The bleeding time tends to be prolonged.[citation needed] With the exception of yellow fever vaccine and Ebola vaccines, ... A viral hemorrhagic fever is a possible cause of the Plague of Athens during the Peloponnesian War. A viral hemorrhagic fever ...
"Yellow fever", Harvard University Gould, Philip (2000). "Race, Commerce, and the Literature of Yellow Fever in Early National ... about the outbreak of the Yellow Fever epidemic Yellow Fever Epidemic of 1793 in Philadelphia in the United States. The first ... Rush believed that blacks might have immunity to the disease, as he had read accounts by another doctor of a yellow fever in ... The city of Philadelphia, the largest city and temporary capital of the United States, suffered a severe yellow fever epidemic ...
Wasserman HA, Singh S, Champagne DE (2004). "Saliva of the Yellow Fever mosquito, Aedes aegypti, modulates murine lymphocyte ... Arthropod-borne viral fevers and viral haemorrhagic fevers, Zoonoses, Tropical diseases, Insect-borne diseases, Animal vaccines ... West Nile fever is an infection by the West Nile virus, which is typically spread by mosquitoes. In about 80% of infections ... West Nile fever (WNF), which occurs in 20 percent of cases, is a febrile syndrome that causes flu-like symptoms. Most ...
"Yellow Fever". Africa Centres for Disease Control and Prevention (Africa CDC). African Union. Retrieved 23 August 2021. African ... "Yellow Fever". Africa Centres for Disease Control and Prevention (Africa CDC). African Union. Retrieved 23 August 2021. African ... Country list - Yellow fever vaccination requirements and recommendations; and malaria situation; and other vaccination ... Yellow Fever vaccination certificate: Countries that require vaccination for all travellers older that 9 months or 1 year: ...
"Yellow Fever". Africa Centres for Disease Control and Prevention (Africa CDC). African Union. Retrieved 23 August 2021. African ... "Yellow Fever". Africa Centres for Disease Control and Prevention (Africa CDC). African Union. Retrieved 23 August 2021. African ... Country list - Yellow fever vaccination requirements and recommendations; and malaria situation; and other vaccination ... Yellow Fever vaccination certificate: Countries that require vaccination for all travellers older that 9 months or 1 year: ...
"Yellow Fever". Africa Centres for Disease Control and Prevention (Africa CDC). African Union. Retrieved 23 August 2021. African ... "Yellow Fever". Africa Centres for Disease Control and Prevention (Africa CDC). African Union. Retrieved 23 August 2021. African ... Country list - Yellow fever vaccination requirements and recommendations; and malaria situation; and other vaccination ... Yellow Fever vaccination certificate: Countries that require vaccination for all travellers older that 9 months or 1 year: ...
"Countries with risk of yellow fever transmission and countries requiring yellow fever vaccination (July 2019)". World Health ... "Yellow Fever". Africa Centres for Disease Control and Prevention (Africa CDC). African Union. Retrieved 23 August 2021. African ... Yellow Fever vaccination certificate: Countries that require vaccination for all travellers older that 9 months or 1 year: ...
"Yellow Fever". Africa Centres for Disease Control and Prevention (Africa CDC). African Union. Retrieved 23 August 2021. African ... "Yellow Fever". Africa Centres for Disease Control and Prevention (Africa CDC). African Union. Retrieved 23 August 2021. African ... Country list - Yellow fever vaccination requirements and recommendations; and malaria situation; and other vaccination ... Yellow Fever vaccination certificate: Countries that require vaccination for all travellers older that 9 months or 1 year: ...
"Yellow Fever". Africa Centres for Disease Control and Prevention (Africa CDC). African Union. Retrieved 23 August 2021. African ... "Yellow Fever". Africa Centres for Disease Control and Prevention (Africa CDC). African Union. Retrieved 23 August 2021. African ... Country list - Yellow fever vaccination requirements and recommendations; and malaria situation; and other vaccination ... Yellow Fever vaccination certificate: Countries that require vaccination for all travellers older that 9 months or 1 year: ...
"Yellow Fever". Africa Centres for Disease Control and Prevention (Africa CDC). African Union. Retrieved 23 August 2021. African ... "Yellow Fever". Africa Centres for Disease Control and Prevention (Africa CDC). African Union. Retrieved 23 August 2021. African ... Country list - Yellow fever vaccination requirements and recommendations; and malaria situation; and other vaccination ... Yellow Fever vaccination certificate: Countries that require vaccination for all travellers older that 9 months or 1 year: ...
Yellow fever. Strongyloidiasis. Certain drugs.[clarification needed] Plague, most commonly from septicemic plague. The source ... Viral hemorrhagic fevers. Gastroenteritis. Gastritis. Chronic viral hepatitis. Hepatic schistosomiasis, or intestinal ...
"Yellow Fever". Africa Centres for Disease Control and Prevention (Africa CDC). African Union. Retrieved 23 August 2021. African ... "Yellow Fever". Africa Centres for Disease Control and Prevention (Africa CDC). African Union. Retrieved 23 August 2021. African ... Country list - Yellow fever vaccination requirements and recommendations; and malaria situation; and other vaccination ... Yellow Fever vaccination certificate: Countries that require vaccination for all travellers older that 9 months or 1 year: ...
"Yellow Fever". Africa Centres for Disease Control and Prevention (Africa CDC). African Union. Retrieved 23 August 2021. African ... "Yellow Fever". Africa Centres for Disease Control and Prevention (Africa CDC). African Union. Retrieved 23 August 2021. African ... Country list - Yellow fever vaccination requirements and recommendations; and malaria situation; and other vaccination ... Yellow Fever vaccination certificate: Countries that require vaccination for all travellers older that 9 months or 1 year: ...
  • Yellow fever occurs in tropical regions of Africa and in parts of South America. (news-medical.net)
  • Yellow fever is a mosquito-borne disease that is endemic to tropical South America and Sub-Saharan Africa (see the image below). (medscape.com)
  • Yellow Fever is endemic in the sylvatic setting in sub-Saharan Africa and the tropical regions of South America. (iamat.org)
  • Yellow Fever outbreaks occur periodically in Africa and have occurred sporadically in South America. (iamat.org)
  • Yellow fever hasn't spread in the US for 100 years, but it still plagues South America and sub-Saharan Africa. (vox.com)
  • Yellow fever had been controlled effectively in West Africa and South America for half a century. (vox.com)
  • While yellow fever is endemic in tropical and subtropical areas of Africa and South America, the virus had not significantly impacted Luanda since the last major outbreak in 1971 . (asm.org)
  • It is important for travelers to be vaccinated before visiting areas where yellow fever exists such as Africa or South America. (ny.gov)
  • The live, attenuated yellow fever (YF) 17D vaccine provides highly effective and durable immunity and is widely used for travelers to and residents of endemic areas of South America and Africa. (greenmedinfo.com)
  • Yellow fever spreads to humans through the bite of an infected mosquito, and outbreaks usually occur in South America and Africa. (fox47news.com)
  • Yellow fever is endemic in tropical areas of 47 countries in Africa and Central and South America, the WHO said. (fox47news.com)
  • There are four types of yellow fever, two in Africa and two in South America, but only three of these have caused outbreaks. (carrington.edu)
  • Yellow fever is typically found in tropical and sub-tropical areas, though mainly in South America and Africa. (carrington.edu)
  • According to the CDC , yellow fever is a mosquito-borne viral disease present in Africa and South America. (passporthealthusa.com)
  • Yellow fever is common in sub-Saharan Africa (where it is endemic), countries in South America and a few other parts of the world. (passporthealthusa.com)
  • Yellow fever is an acute viral hemorrhagic disease transmitted by infected mosquitoes and is endemic in tropical areas of Africa and Central and South America. (meridianbioscience.com)
  • Yellow fever vaccine is recommended for persons aged 9 months or older who are living in or traveling to areas with risk of yellow fever virus transmission, such as places in Africa and South America. (wa.gov)
  • Yellow fever occurs only in the tropical areas of Central Africa, southern Panama, and South America. (msdmanuals.com)
  • Yellow fever virus, a flavivirus, is transmitted to humans through the bite of infected mosquitoes. (news-medical.net)
  • Yellow fever disease is diagnosed based on symptoms, physical findings, laboratory testing, and the possibility of exposure to infected mosquitoes. (news-medical.net)
  • Researchers from the Johns Hopkins Malaria Research Institute at the Johns Hopkins Bloomberg School of Public Health have made an important finding about Aedes aegypti mosquitoes-;one that could one day lead to better methods for reducing the mosquito-to-human transmission of dengue, yellow fever, Zika, and other harmful and sometimes deadly viruses. (news-medical.net)
  • Humans infected with YF virus experience the highest levels of viremia shortly before onset of fever and for the first 3-5 days of illness, during which time they can transmit the virus to mosquitoes. (cdc.gov)
  • Yellow fever is spread by types of Aedes and Haemagogus mosquitoes that carry the disease. (mydr.com.au)
  • Depending on where you are travelling, protecting yourself against mosquito bites can also help prevent you being infected with other diseases that are spread by mosquitoes, such as malaria and dengue fever. (mydr.com.au)
  • In the sylvatic cycle , Yellow Fever is transmitted by mosquitoes that bite infected monkeys passing the infection to humans living in or visiting jungle areas. (iamat.org)
  • In the urban cycle , infected mosquitoes transmit Yellow Fever from person to person that can cause large outbreaks in cities and suburbs. (iamat.org)
  • Areas with greater population densities and higher numbers of man-made habitats where mosquitoes can lay their eggs increase the risk of yellow fever transmission in the urban setting. (asm.org)
  • Yellow fever can affect people of any age especially people travelling to areas where mosquitoes infected with yellow fever virus are found. (ny.gov)
  • Yellow fever is spread by the bite of infected Aedes aegypti mosquitoes. (ny.gov)
  • Like Zika, yellow fever is spread by infected mosquitoes. (consumeraffairs.com)
  • Strategies used to combat mosquitoes may also work on yellow-fever-carrying mosquitoes. (factsanddetails.com)
  • Yellow fever is an acute viral haemorrhagic disease transmitted by infected mosquitoes, mainly Aedes aegypti . (who.int)
  • Yellow fever is a disease spread by the bite of infected female mosquitoes. (africageographic.com)
  • Yellow fever is a potentially deadly viral hemorrhagic disease transmitted by infected mosquitoes and its vaccine provides up to 99% lifetime immunity. (fox47news.com)
  • While yellow fever may be rare for visitors to northern countries, including the United States, it is transmitted by infected mosquitoes, so care should always be taken. (carrington.edu)
  • Yellow fever is transmitted to humans through mosquitoes. (carrington.edu)
  • Washington State does not have the type of mosquitoes known to carry the yellow fever virus. (wa.gov)
  • Aedes aegypti mosquitoes infect 200,000 people with yellow fever annually, resulting in 30,000 deaths. (nd.edu)
  • Mosquitoes that carry malaria, dengue fever and yellow fever avoid homes that have been sprayed with DDT, researchers reported on Wednesday. (instapundit.com)
  • But in 15% of cases, people enter a second, toxic phase of the disease characterized by recurring fever, this time accompanied by jaundice due to liver damage, as well as abdominal pain. (wikipedia.org)
  • Jaundice, fatigue, heart rhythm problems, seizures and internal bleeding may also appear as complications of yellow fever during recovery time. (wikipedia.org)
  • It is called 'yellow fever' because of the yellow skin colour (jaundice) that develops in people with severe disease. (mydr.com.au)
  • Yellow fever victims often suffer from jaundice (a liver disease that yellows the skin), hence the name yellow fever. (factsanddetails.com)
  • The "yellow" in the name refers to the jaundice that affects some patients. (who.int)
  • They are similar to the flu and could become severe to include fever, headache, muscle pain, nausea, vomiting, fatigue and jaundice -- hence its name yellow fever. (fox47news.com)
  • It derives all of its names from the jaundice (due to liver damage) that occurs in advanced cases, which turns the skin and eyes yellow. (carrington.edu)
  • Most people infected with Yellow fever do not experience any symptoms but when they do occur, there is a risk of advancing to a toxic phase in which people develop jaundice, dark urine, and abdominal pain and have a 50% chance of dying. (meridianbioscience.com)
  • Patients develop the jaundice that gives yellow fever its name. (npr.org)
  • Illness ranges from fever to bleeding and jaundice (yellowing skin or eyes). (wa.gov)
  • One in seven people will feel better for a few hours or a day, but then develop more severe disease, which includes symptoms such as high fever, jaundice (yellow skin or eyes), and bleeding, and eventually shock and organ failure. (wa.gov)
  • It was called bronze John, bilious fever, the saffron scourge, and yellow jack-all these names derived from the jaundice that usually accompanied the disease. (cigarcitymagazine.com)
  • Some people with yellow fever have no or mild symptoms, but others have more severe symptoms such as yellow skin (jaundice), fever, headache, muscle aches, and bleeding. (msdmanuals.com)
  • Jaundice in Adults In jaundice, the skin and whites of the eyes look yellow. (msdmanuals.com)
  • Jaundice occurs when there is too much bilirubin (a yellow pigment) in the blood-a condition called hyperbilirubinemia. (msdmanuals.com)
  • The last epidemic of yellow fever in North America occurred in New Orleans in 1905. (news-medical.net)
  • At a time when global yellow fever vaccine supplies are diminished, an epidemic in a densely populated city could have substantial health and economic consequences," the researchers warned. (vox.com)
  • The first yellow fever epidemic was reported in 1648, according to JAMA . (vox.com)
  • However, beginning in December of 2016, Brazil suffered a massive epidemic that affected coastal areas where yellow fever had not been registered for decades. (unicef.org)
  • For example, thousands of people became infected with the disease in 2016 during a yellow fever epidemic in Angola and the Congo. (mpg.de)
  • This was the 1793 yellow fever epidemic in Philadelphia, which overwhelmed the city's residents, Quakers and non-Quakers alike, from August to November. (pym.org)
  • An American Plague: The True and Terrifying Story of the Yellow Fever Epidemic of 1793" dramatically recounts the true story of the yellow fever epidemic that nearly decimated the population of Philadelphia at the end of the 18th century. (ala.org)
  • In 1887- 188, Tampa experienced the worst of the Yellow Fever epidemic! (cigarcitymagazine.com)
  • They were victims of yellow fever, a grim epidemic that struck Tampa repeatedly in the city's early history-five times, from the city's charter in 1850 to 1905, when the last case was reported. (cigarcitymagazine.com)
  • During the yellow fever epidemic in Angola in 2016, cases of yellow fever were reported in China for the first time. (who.int)
  • A Yellow Fever Epidemic: A New Global Health Emergency? (who.int)
  • It was estimated that given the widespread distribution of the Aedes aegypti mosquito to every continent , nearly 3 billion people were at risk of acquiring yellow fever infection. (asm.org)
  • The Aedes aegypti mosquito is most commonly associated with spreading yellow fever. (ny.gov)
  • aedes Yellow fever is the second most dangerous mosquito-borne disease after malaria. (factsanddetails.com)
  • Urban yellow fever is carried the " Aedes aegypti" mosquito. (factsanddetails.com)
  • Yellow fever is transmitted by Aedes aegypti mosquitos. (factsanddetails.com)
  • In 2007, scientists published the genome - a map of all the DNA - of the Aedes aegypti, the mosquito that carries yellow fever and dengue fever. (factsanddetails.com)
  • The Aedes mosquito can transmit several viruses including dengue, yellow fever and Zika. (theconversation.com)
  • The so-called "yellow fever mosquito" Aedes aegypti is the main vector for yellow fever. (carrington.edu)
  • Now, researchers at Rockefeller University have harnessed a technique known as CRISPR-Cas9 editing in an important and understudied species: the mosquito, Aedes aegypti, which infects hundreds of millions of people annually with the deadly diseases chikungunya, yellow fever, and dengue fever. (science20.com)
  • Notre Dame entomologist David Severson and his colleagues announced this spring that they have successfully mapped the DNA for Aedes aegypti , the mosquito that spreads yellow fever and dengue fever. (nd.edu)
  • Sindbis virus is suppressed in the yellow fever mosquito Aedes aegypti by ATG-6/Beclin-1 mediated activation of autophagy. (bvsalud.org)
  • To address this gap, we use a genetic approach to activate macroautophagy / autophagy in the yellow fever mosquito ( Aedes aegypti ), infected with a recombinant Sindbis virus (SINV) expressing an autophagy activator. (bvsalud.org)
  • Illness ranges in severity from a self-limited febrile illness to severe hepatitis and hemorrhagic fever. (news-medical.net)
  • Its presentation can range from asymptomatic illness to acute-onset viral hepatitis and hemorrhagic fever. (medscape.com)
  • Yellow fever is one of many causes of viral hemorrhagic fever . (medscape.com)
  • This is why yellow fever is a hemorrhagic fever. (vox.com)
  • SummaryYellow Fever (YF) is an acute viral hemorrhagic fever disease caused by Yellow Fevervirus (YFV) and an estimated 200,000 YF infections occur annually. (sbir.gov)
  • More severe symptoms include hepatitis and hemorrhagic fever. (passporthealthusa.com)
  • Yellow fever, caused by one of a group of disease agents called flaviviruses, is a form of tropical hemorrhagic fever. (cigarcitymagazine.com)
  • Yellow fever vaccine may be given at the same time as most other vaccines. (medlineplus.gov)
  • The technologies developed in this project couldeventually provide a platform technology for quick development of safe, thermostable,and effective vaccines against other emerging diseases.Project NarrativeThis research first explores feasibility of producing a safe, effective, low cost thermostablevaccine against Yellow Fever virus, which could ultimately be administered to patients viarespiratory or non-needle delivery. (sbir.gov)
  • For this project, wild-type Yellow Fever virus will bethermostabilized by Universal Stabilization Technologies' innovative "Preservation byVaporization" process, followed by electron beam inactivation to create a potent vaccine.The technologies developed in this project could eventually become a platform technologyfor quick development of safe, effective, and thermostable vaccines against otherinfectious diseases. (sbir.gov)
  • The Angolan military administers yellow fever vaccines at a market in Luanda, the capital city. (npr.org)
  • The world is in danger of running out of vaccines for a deadly disease: yellow fever. (npr.org)
  • Yellow Fever vaccines are required or strongly recommended for travel to certain countries. (jotform.com)
  • The St Helena Health Services Directorate has recently procured a batch of Yellow Fever vaccines for the purpose of vaccinating persons travelling to or via Accra. (sainthelena.gov.sh)
  • Yellow fever vaccines and international travelers. (medscape.com)
  • However, travelers going to areas with ongoing outbreaks may consider getting a booster dose of yellow fever vaccine if it has been 10 years or more since they were last vaccinated. (cdc.gov)
  • In areas where yellow fever is common, early diagnosis of cases and immunization of large parts of the population are important to prevent outbreaks. (wikipedia.org)
  • These shortages have coincided with some of the largest yellow fever outbreaks in half a century. (vox.com)
  • Comparison of yellow fever predicted probability map with Yellow Fever Vaccination Recommendations map: counties in the upper probability classes correlated spatially with the recommended vaccination areas prior recent outbreaks. (unicef.org)
  • There is a limited global supply of yellow fever vaccine, as only a handful of manufacturers produce it, making the availability of vaccine during outbreaks a major challenge. (asm.org)
  • Recent yellow fever outbreaks have pushed the World Health Organization (WHO) to consider fractional doses to increase vaccine access and lower the potential of yellow fever to spread. (asm.org)
  • While this may seem like a simple and obvious solution for outbreaks like the one in Angola, there is a significant challenge: a yellow fever vaccine shortage. (asm.org)
  • In 2017, over 50 partners launched the Eliminate Yellow fever Epidemics (EYE) Strategy: an unprecedented partnership supporting 40 at-risk countries in Africa and the Americas to protect at-risk populations, prevent international spread, and contain outbreaks rapidly. (who.int)
  • The paper-appearing in a recent edition of the American Journal of Primatology -focuses on yellow fever outbreaks that were documented in several howler monkey populations of Misiones Province, Argentina. (phys.org)
  • The authors of the paper initiated their research as an ecological study of two howler monkey species of El Piñalito Provincial Park in January 2005, a project that enabled them to detect the first occurrence of two yellow fever outbreaks between November 2007 and October 2008. (phys.org)
  • Brazil has seen several outbreaks of yellow fever since the beginning of 2017 but the country's government had said the virus stopped spreading in September, according to the World Health Organization . (fox47news.com)
  • Various forms of this 1899 yellow fever immunity card were employed in fever outbreaks by those who had to travel in and out of affected areas and who could certify immunity. (cigarcitymagazine.com)
  • A safe and effective vaccine against yellow fever exists, and some countries require vaccinations for travelers. (wikipedia.org)
  • Yellow fever is a very rare cause of illness in U.S. travelers. (news-medical.net)
  • None of the travelers had been immunized for yellow fever prior to their trips, and many cases involved infections on Ilha Grande, an island off the coast of Rio de Janeiro that's popular with tourists. (vox.com)
  • There are more cases of imported yellow fever [from travelers] in the past two years than in the previous 20 years," said Duane Gubler , a leading researcher of mosquito-borne diseases at Duke-NUS Medical School. (vox.com)
  • The researchers found that America was among a handful countries with a high volume of travelers - 2.76 million people - coming from places with yellow fever. (vox.com)
  • According to the latest guidance from the Centers for Disease Control and Prevention (CDC), yellow fever is "a very rare cause of illness" in U.S. travelers. (consumeraffairs.com)
  • From 1990 to the present, the number of cases (n = 31) and deaths (n = 12) from the yellow fever vaccine in travelers has exceeded the reports of YF (n = 6) acquired by natural infection. (greenmedinfo.com)
  • Health officials are urging travelers headed to Brazil to get yellow fever vaccinations due to a recent deadly outbreak of the virus. (fox47news.com)
  • In addition to receiving a yellow fever vaccine, travelers should be sure to use appropriate mosquito repellents or netting. (passporthealthusa.com)
  • The yellow fever vaccine provides protection against the virus for travelers and those living in areas where the disease is present. (passporthealthusa.com)
  • Only registered Yellow Fever Vaccination Centers like Passport Health can give the yellow fever vaccine and provide the International Certificate of Vaccination ("yellow card") to travelers and other individuals. (passporthealthusa.com)
  • A vaccine is available for use by people residing in endemic countries and for travelers to areas where yellow fever is common, but avoiding mosquito bites is also important. (msdmanuals.com)
  • Updates on yellow fever vaccination recommendations for international travelers related to the current situation in Brazil. (who.int)
  • Yellow fever usually has an 'acute' phase, with a sudden onset of fever, nausea, vomiting, muscle aches and headache. (mydr.com.au)
  • People who get symptoms usually have a sudden onset of fever, chills, severe headache, backache, weakness, nausea (a sick feeling in the stomach) and vomiting. (ny.gov)
  • Some people then recover, but others develop a high fever, nausea, vomiting, and severe generalized pain a few hours or days after the initial symptoms subside. (msdmanuals.com)
  • In 15%-25% of individuals with yellow fever, symptoms recur during the period of intoxication and can progress to fatal illness. (medscape.com)
  • Yellow fever is an illness of varying severity caused by an infection with a type of virus known as a flavivirus. (mydr.com.au)
  • But 15 percent of patients experience a much more severe second phase of the illness, which brings high fever, yellowing of the skin and eyes, internal bleeding, and organ failure. (vox.com)
  • In a little over a month, 23 additional cases of yellow fever were reported among Eritrean and Congolese citizens living in Luanda , 7 of whom died from their illness. (asm.org)
  • Most people infected with yellow fever virus have no illness or mild illness. (ny.gov)
  • Up to half of the people who develop severe illness from yellow fever will die about 10 - 14 days later. (carrington.edu)
  • The Mail on Sunday can now reveal that his absence from the screen earlier this year was due to an extreme illness after receiving a yellow fever vaccination. (whale.to)
  • For most people, a single dose of yellow fever vaccine provides long-lasting protection and a booster dose of the vaccine is not needed. (cdc.gov)
  • Anyone with a severe (life-threatening) allergy to any component of the vaccine, including eggs, chicken proteins, or gelatin, or who has had a severe allergic reaction to a previous dose of yellow fever vaccine should not get yellow fever vaccine. (medlineplus.gov)
  • Interestingly, while WHO recommends a potency of 1,000 International Units (IUs) for a full dose of yellow fever vaccine, the actual potency is variable and ranges from about 13,000 to nearly 44,000 IUs per dose . (asm.org)
  • Talk to your healthcare provider to determine if you need a yellow fever vaccination or a booster shot before your trip to an area at risk for yellow fever. (cdc.gov)
  • A family is vaccinated against yellow fever at an outpatient clinic in Sao Paulo, Brazil, where an large outbreak of yellow fever began in 2016. (vox.com)
  • In 2016, we saw the most cases [of yellow fever] in decades," Gubler said. (vox.com)
  • The Yellow Fever situation report of 02 June 2016 has been posted. (who.int)
  • By 2016, Angola reported more than 4,000 suspected infections (884 confirmed) and 376 suspected deaths (121 confirmed) from yellow fever . (asm.org)
  • Protocol for prevention and control for yellow fever(the 2016 version). (who.int)
  • The A aegypti mosquito is a known transmitter of dengue fever and yellow fever. (medscape.com)
  • Dengue fever and yellow fever are so closely related they are regarded as sister diseases. (factsanddetails.com)
  • Philadelphia lost ten percent of its population in one outbreak in 1793, and the urban mortality rates from yellow fever reached 50 percent in some cities in the 19th century. (factsanddetails.com)
  • There was no cure for yellow fever, but in 1793 well-known Dr. Benjamin Rush was convinced that bleeding was the most likely cure. (pym.org)
  • It is one of the viral hemorrhagic fevers, thus named because they may lead to fever and hemorrhaging. (carrington.edu)
  • Yellow fever (YF) virus is a single-stranded RNA virus that belongs to the genus Flavivirus . (cdc.gov)
  • Yellow Fever is a viral infection caused by RNA viruses belonging to the Flavivirus genus. (iamat.org)
  • Native to tropical West Africa, yellow fever is a viral infection, of the genus Flavivirus that also includes dengue fever, West Nile virus and Japanese encephalitis, among others. (theglobalist.com)
  • The yellow fever virus is an RNA virus of the Flavivirus genus, which also includes West Nile virus and Dengue Fever. (carrington.edu)
  • In 2013, yellow fever was estimated to have caused 130,000 severe infections and 78,000 deaths in Africa. (wikipedia.org)
  • Yellow fever can lead to death for 20% to 50% of those who develop severe disease. (wikipedia.org)
  • The shortage was so severe during the 2015-2017 outbreak that the allotted global stockpile of yellow fever vaccine (6 million doses) was depleted numerous times . (asm.org)
  • 30 to 60% of people with severe bleeding and fever die. (msdmanuals.com)
  • You first feel a little achy and then there is a sudden onset of fever, the malaise and then there's these headaches," says Ilhem Messaoudi , an infectious disease specialist at the University of California, Riverside. (npr.org)
  • As the disease progresses, yellowing of the whites of the eyes and skin, slowing and weakening of the heart rate, bleeding of the gums, and bloody urine may occur. (ny.gov)
  • Therefore, the Health Services Directorate is offering Yellow Fever vaccinations to any persons who are planning upcoming travel via Accra. (sainthelena.gov.sh)
  • The global community needs to carefully reexamine existing yellow fever travel vaccination policies and practices to prevent urban epidemics. (vox.com)
  • In the U.S., the city of New Orleans was devastated by yellow fever epidemics in the 19th century. (consumeraffairs.com)
  • In the past, major epidemics of yellow fever caused tens of thousands of deaths. (msdmanuals.com)
  • Two Georgetown University professors say the outbreak of yellow fever around the world, which so far has spread without much notice, is becoming the world's newest health emergency. (consumeraffairs.com)
  • The current outbreak of yellow fever began at the end of 2017 after several cases were confirmed in areas close to São Paulo, the CDC said. (fox47news.com)
  • Yellow fever is a viral disease of typically short duration. (wikipedia.org)
  • The disease is caused by the yellow fever virus and is spread by the bite of an infected mosquito. (wikipedia.org)
  • Yellow fever is a serious disease caused by the yellow fever virus. (medlineplus.gov)
  • People with yellow fever disease usually have to be hospitalized. (medlineplus.gov)
  • Yellow fever is an endemic disease in Africa and the Americas. (unicef.org)
  • Yellow fever risk assessment using these factors is key to designing vaccination and other intervention campaigns aimed at reducing the burden of the disease. (unicef.org)
  • In April 2017, for example, the US Center for Disease Control announced that the only licensed vaccine against yellow fever would no longer be available in the United States by the end of 2018. (mpg.de)
  • Yellow fever is a disease caused the bite of a mosquito infected with the yellow fever virus. (ny.gov)
  • Jungle yellow fever is an enzootic disease transmitted among nonhuman primate hosts by a variety of species of mosquitos. (factsanddetails.com)
  • Although a yellow fever vaccine has been available since the 1930s, the disease continues to afflict 200,000 people a year, a third of whom die, mostly in West Africa. (factsanddetails.com)
  • Yellow Fever sometimes picked by mosquitos from monkeys that carry the disease with no ill effects. (factsanddetails.com)
  • In the 2000s, there were around 200,000 new cases of yellow fever and 20,000 to 30,000 deaths attributed to the disease each years. (factsanddetails.com)
  • Renowned U.S. Army pathologist Walter Reed discovered the cause of yellow fever during an outbreak of the disease during the Spanish American war in Cuba. (factsanddetails.com)
  • In a retrospective analysis of patients with yellow fever vaccine-associated viscerotropic disease accompanied by shock, 75% of those treated with stress-dose steroids survived, compared with 29% of those not treated with stress-dose steroids. (medscape.com)
  • Symptoms of the spreading disease included high fevers, hemorrhages, yellow eyes and skins and black vomit. (pym.org)
  • Because the yellow fever vaccine is very safe and the disease risk is high, the CDC recommends this vaccine for adults and children over 9 months who will be traveling to high-risk areas. (passporthealthusa.com)
  • Yellow fever is a forgotten disease," he says. (npr.org)
  • The mosquito also causes up to 100 million cases of dengue fever, a potentially fatal disease. (nd.edu)
  • Yellow fever is a mosquito-borne viral disease that occurs mainly in the tropics. (msdmanuals.com)
  • It examines case detection and disease control and surveillance, and presents recommendations for further action to prevent additional importation of yellow fever into China. (who.int)
  • The currently available yellow fever vaccine confers near lifelong immunity in 95% of patients. (medscape.com)
  • People who have had yellow fever generally develop lifelong immunity. (ny.gov)
  • Use of yellow fever vaccine which offers life-long immunity can protect one from yellow fever. (who.int)
  • Yellow fever was a pestilence brought to the New World as part of the sad inheritance of slavery since it traveled in slave ships from West Africa, where it was and remains endemic, to the New World. (cigarcitymagazine.com)
  • In 1927, yellow fever virus was the first human virus to be isolated. (wikipedia.org)
  • Yellow fever is caused by Yellow fever virus (YFV), an enveloped RNA virus 40-50 nm in width, the type species and namesake of the family Flaviviridae. (wikipedia.org)
  • Yellow fever vaccine is a live, weakened virus. (medlineplus.gov)
  • Laboratory personnel who might be exposed to yellow fever virus or vaccine virus. (medlineplus.gov)
  • As Brazil battles the biggest yellow fever outbreak in modern times , researchers are warning of the risk of the virus spreading internationally. (vox.com)
  • Yet the US also doesn't require people to show a yellow fever card proving they've been vaccinated against the virus. (vox.com)
  • Evaluate protective efficacy of the YFV vaccine candidate againstviscerotropic YF in a hamster model.Our immediate goal is to prove feasibility of a safe, effective, low-cost thermostablevaccine against Yellow Fever virus. (sbir.gov)
  • Yellow fever vaccine is still produced by the original methods used by Dr. Max Theiler and his team when they developed the vaccine in the 1930s-growing the virus in eggs repeatedly until a viral load is reached that is considered acceptable for administration. (asm.org)
  • The diagnosis of yellow fever is performed through virological (namely, detection of the viral genome, detection of viral antigens, or virus isolation) and/or serological methods (ELISA, PRNT) (5-7). (paho.org)
  • Sudan conducted a yellow fever risk assessment exercise in early 2013 and confirmed that the yellow fever virus was circulating in all parts of the country. (who.int)
  • Apart from Sudan, serological evidence of circulation of yellow fever virus has been documented in Djibouti and Somalia. (who.int)
  • Yellow fever is caused by a virus from Africa that was brought to the Americas by colonists and the slave trade and still affects people in tropical areas. (phys.org)
  • Yellow fever is caused by a virus and is also known as the yellow plague or yellow jack. (carrington.edu)
  • Yellow fever virus has three transmission cycles: jungle (sylvatic), inter-mediate (savannah), and urban. (carrington.edu)
  • How can I protect myself from yellow fever virus? (wa.gov)
  • Non-transfected (-) and transfected (+) 293T whole cell extracts (30 μg) were separated by 10% SDS-PAGE, and the membrane was blotted with Yellow Fever Virus NS5 protein antibody (GTX134141) diluted at 1:5000. (genetex.com)
  • 182 : 104907 Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus. (genetex.com)
  • There are currently no reviews for Yellow Fever virus NS5 protein antibody (GTX134141) . (genetex.com)
  • Doctors diagnose yellow fever by growing (culturing) the virus, by doing blood tests to detect antibodies to the virus, or by using polymerase chain reaction (PCR) techniques to help identify the virus's genetic material. (msdmanuals.com)
  • Poor antibody response to yellow fever vaccination in children infected with human immunodeficiency virus type 1. (medscape.com)
  • Goujon C, Tohr M, Feuille V. Good tolerance and efficacy of yellow fever vaccine among subjects who are carriers of human immunodeficiency virus. (medscape.com)
  • After recently writing an article titled ' History of Yellow Fever in the United States ,' I spoke with Dr. Derick Kimathi , a clinical researcher at the Kenya Medical Research Institute-Wellcome Trust Research Programme (KEMRI-Wellcome Trust) who is investigating the safety and efficacy of using smaller doses of yellow fever vaccine to induce similar immunologic protection as standard doses (also known as fractional dosing). (asm.org)
  • This is a slow, tedious process yielding 100-300 doses per egg , and there are only 4 major yellow fever vaccine manufacturers in the world. (asm.org)
  • A Yellow Fever Vaccination clinic was held on 23 June, following which a small number of doses are still available. (sainthelena.gov.sh)
  • Staples JE, Bocchini JA Jr, Rubin L, Fischer M. Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015. (medscape.com)
  • Yellow fever vaccine is given only at designated vaccination centers. (medlineplus.gov)
  • People traveling to areas where yellow fever exists should speak with their health care provider about receiving the yellow fever vaccine. (ny.gov)
  • There is no specific treatment for yellow fever, but there is a vaccine that is highly effective and offers lifelong protection after just one dose . (asm.org)
  • What is the treatment for yellow fever? (ny.gov)
  • There is currently no specific treatment for yellow fever, although proper case management improves survival rate. (who.int)
  • After getting the vaccine, you should be given a stamped and signed ''International Certificate of Vaccination or Prophylaxis'' (yellow card). (medlineplus.gov)
  • Proof of YF vaccination is recorded on the International Certificate of Vaccination or Prophylaxis (i.e., yellow card). (cdc.gov)
  • New Cleveland Clinic research shows how mosquito-transmitted viruses - like Zika, West Nile, Yellow Fever and dengue viruses - hijack host cells to promote their own replication and infection. (news-medical.net)
  • Children under 6 months of age, persons with immune deficiencies or on immunosuppressive or immunomodulatory therapies, persons with allergies to egg proteins, thymus disorders, malignant neoplasms, transplant recipients, and persons with symptomatic HIV infection should not get the Yellow Fever vaccine. (iamat.org)
  • Does past infection with yellow fever make a person immune? (ny.gov)
  • Doctors suspect yellow fever when people living in an area where the infection is common have typical symptoms. (msdmanuals.com)
  • Approximately 90 percent of an estimated 200,000 cases of yellow fever per year occur in Africa. (wikipedia.org)
  • Where does yellow fever occur? (mydr.com.au)
  • Direct spread of yellow fever from one person to another does not occur. (ny.gov)
  • Consult your health department or visit CDC's travel information website at http://www.cdc.gov/travel to learn yellow fever vaccine requirements and recommendations for different countries. (medlineplus.gov)
  • For details, see Map 5-10 , Map 5-11 , and YF vaccine recommendations (Sec. 2, Ch. 5, Yellow Fever Vaccine & Malaria Prevention Information, by Country ). (cdc.gov)
  • Recommendations to control yellow fever included conducting preventive campaigns with the yellow fever vaccine, of which a single dose provides lifelong protection. (who.int)
  • Staples JE, Gershman M, Fischer M. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). (medscape.com)
  • Barnett ED. Yellow fever: epidemiology and prevention. (medscape.com)
  • Research on the important measures for yellow fever prevention and control from the authority of IHR and the embassy of Angola. (who.int)
  • Researchers are combining several approaches for the production of flaviviruses under ideal conditions, including the pathogen that causes yellow fever. (mpg.de)
  • A long list of novel small molecules have shown activity against yellow fever and other flaviviruses in vitro or in animal models, but none is currently available clinically. (medscape.com)
  • Zika, dengue, yellow fever: what are flaviviruses? (org.in)
  • What are the symptoms of yellow fever and when do they appear? (ny.gov)
  • Symptoms of yellow fever usually begin three to six days after a bite and last about three or four days. (fox47news.com)
  • The symptoms of yellow fever are quite varied. (carrington.edu)
  • What are the symptoms of yellow fever? (wa.gov)
  • Symptoms of yellow fever usually appear about 3 to 6 days after being bitten by an infected mosquito. (msdmanuals.com)
  • Yellow fever is one of the most easily recognized and historically important viral infections. (msdmanuals.com)
  • After World War II, DDT was used to get rid of mosquitos around the world and yellow fever as well as malaria, dengue and other diseases were declared "under control. (factsanddetails.com)
  • In about 15% of people, within a day of improving the fever comes back, abdominal pain occurs, and liver damage begins causing yellow skin. (wikipedia.org)
  • The fever comes back, as well as abdominal pain and vomiting. (mydr.com.au)
  • Since the 1980s, the number of cases of yellow fever has been increasing. (wikipedia.org)
  • No cases of yellow fever have been reported in Australia. (mydr.com.au)
  • A global uptick in yellow fever cases is coinciding with a vaccine shortage. (vox.com)
  • That is, the 640 municipalities that have had yellow fever cases were all correctly recalled, and 31 yellow fever free counties were predicted to have cases. (unicef.org)
  • Reported cases of yellow fever in the Americas. (unicef.org)
  • Probability of yellow fever cases as predicted by the algorithm. (unicef.org)
  • The first suspected cases of yellow fever were reported in individuals visiting Luanda from Eritrea . (asm.org)
  • The number of cases of yellow fever dropped from 1,400 cases in 1900 to 37 in 1901. (factsanddetails.com)
  • There is mandated reporting to the WHO of all suspected or confirmed yellow fever cases within 24 hours of detection. (medscape.com)
  • Brazil is the only country where new cases of yellow fever have been reported this year, the Pan American Health Organization said. (fox47news.com)
  • Fatal cases of yellow fever have occurred in unvaccinated tourists visiting areas within the yellow fever endemic zone. (passporthealthusa.com)
  • In fact there've already been some cases of yellow fever imported to China during this Angola outbreak. (npr.org)
  • Total number of new yellow fever cases for the week ending 20 September: 80. (genealogy-quest.com)
  • This paper reviews the epidemiological characteristics of the 11 yellow fever cases imported into China. (who.int)
  • While yellow fever is not present throughout the globe, yellow fever vaccination is important because of the virus's high mortality rate. (passporthealthusa.com)
  • The yellow fever vaccine "is only effective if received at least 10 days prior to arrival in an at-risk area," the CDC said. (fox47news.com)
  • Yellow fever is spread through the bite of an infected mosquito. (medlineplus.gov)
  • Fatal yellow fever in a traveler returning from Amazonas, Brazil, 2002. (medscape.com)